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 Abbreviations 
 
2D  two-dimensional 
3D  three-dimenstional 
Aβ  amyloid-beta-peptide 
AD  Alzheimer‘s disease 
APP  amyloid precursor protein 
BACE  beta-site amyloid protein cleaving enzyme (β-secretase) 
cbro  cerebrosides 
chol  cholesterol 
cmc  critical micellar concentration 
DDM  dodecylmaltoside 
EM  electron microscopy 
FCS  fluorescence correlation spectroscopy 
GPL  glycerophospholipids 
GSL  glycosphingolipids 
GUV  giant unilamellar vesicle 
hrs  hours 
ld  liquid-disordered phase 
lo  liquid-ordered phase 
LUV  large unilamellar vesicle 
mβCD  methyl-beta-cyclodextrin 
min  minutes 
OG  octylglucoside 
PA  phosphatidic acid 
PC  phosphatidylcholine 
PE  phosphatidylethanolamine 
PI  phosphatidylinositol 
PL  phospholipids 
POPC  palmitoyl-oleoyl phosphatidylcholine 
PS  PreScission protease 
RT  room temperature 
sec  seconds 
SEM  standard error of the mean 
SL  sphingolipids 
TAP  tandem affinity purification tag 
TBLE  total brain lipid extract 
TEV  tobacco-etch virus 
TLC  thin-layer chromatography 
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1. Summary 
Proteolytic processing of the amyloid precursor protein (APP) may lead to the 
formation of the Aβ peptide, the major constituent of amyloid plaques in 
Alzheimer‘s disease. The full-length APP is a substrate for at least 2 different 
(α and β) proteases (”secretases”). The β-secretase, BACE, cleaves APP in the 
first step of processing leading to the formation of the neurotoxic Aβ. BACE 
competes for APP with  α-secretase, which cleaves APP within its Aβ 
sequence, thus precluding Aβ formation. It is thus important to understand 
how is the access of the  α- and β-secretase to APP regulated and how are the 
individual activities of these secretases modulated. Both these regulatory 
mechanisms, access to substrate and direct activity modulation, can be 
determined by the lipid composition of the membrane.  
Integral membrane proteins (like APP and BACE), can be viewed as solutes in 
a two-dimensional liquid membrane, and as such their state, and biological 
activity, critically depend on the physico-chemical character (fluidity, 
curvature, surface charge distribution, lateral domain heterogeneity etc.) of the 
lipid bilayer. These collective membrane properties will influence the activity of 
embedded membrane proteins. In addition, activity regulation may involve a 
direct interaction with a specific lipid (cofactor or co-structure function). 
Interactions of membrane proteins are furthermore affected by lateral domain 
organization of the membrane.  
Previous results had suggested that the regulation of the activity of the  α- and 
β-secretases and of their access to APP is lipid dependent, and involves lipid 
rafts. Using the baculovirus expression system, we have purified recombinant 
human full-length APP and BACE to homogeneity, and reconstituted them in 
large (˜100nm, LUVs) and giant (10-150µm, GUVs) unilamellar vesicles. 
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Using a soluble peptide substrate mimicking the β-cleavage site of APP, we 
have examined the involvement of individual lipid species in modulating BACE 
activity in LUVs of various lipid compositions. We have identified 3 groups of 
lipids that stimulate proteolytic activity of BACE: 1.cerebrosides, 2.anionic 
glycerophospholipids, 3. cholesterol. 
Furthermore, we have co-reconstituted APP and BACE together in LUVs and 
demonstrated that BACE cleaves APP at the correct site, generating the β-
cleaved ectodomain identical to that from cells. We have developed an assay to 
quantitatively follow the β-cleavage in proteoliposomes, and we have shown 
that the rate of cleavage in total brain lipid proteoliposomes is higher than in 
phosphatidylcholine vesicles. 
We have also studied partitioning of APP and BACE in GUVs between liquid 
ordered (lo) and liquid disordered (ld) phases. In this system, significant part 
of the BACE pool (about 20%) partitions into the lo phase, and its 
partitioning into lo phase can be further enhanced by cross-linking of 
membrane components. Only negligible fraction of APP can be found in the lo 
phase. We continue to study the behavior of co-reconstituted APP and BACE 
in GUVs 
The work presented in this thesis has yielded some interesting results and 
raised further questions. One of the important assignments of this project will 
in the next stage be the characterization of the impact of membrane domain 
organization on the β-cleavage. Different domain arrangements that can be 
hypothesized in cell membranes can be modeled by varying the degree of phase 
fragmentation in proteoliposomes comprising reconstituted APP and BACE. 
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2. Introduction 
Millions of people worldwide suffer from Alzheimer’s disease (AD). The risk of 
the disease increases with age. Between 6-10% of people aged 65 or below suffer 
from AD, while almost a half of the population of 85 years or older are affected 
[1]. AD is a devastating neurodegenerative disease. The disease develops 
gradually, beginning almost imperceptibly with minor lapses of episodic 
memory, progressing over the years to result in massive memory and cognition 
decline, eventually leading to dementia [2]. Invariable physiological changes 
characteristic for AD pathology include presence of neurofibrillar tangles of 
hyperphosphorylated Tau protein and the senile plaques composed mainly of 
the aggregated amyloid β-peptide (Aβ) [3]. While the polymeric Tau structures 
are intracellular, the Aβ-aggregates accumulate on the cell surface, indicating 
that the cell membrane should be regarded as a potential participant in plaque 
deposition process. Indeed, the Aβ peptide is a product of a membrane-
associated reaction. 
Cellular membranes accommodate a vast variety of membrane associated 
proteins. Genomic analyses indicate that 25-40% of all proteins are membrane 
proteins. In this thesis, the focus lies on two such proteins: amyloid precursor 
protein (APP) and β-site amyloid cleaving enzyme (BACE) that react to 
produce the aforementioned beta-amyloid (Aβ  peptide). 
APP is a relatively large (˜100kDa) integral membrane protein of type I (1 
transmembrane segment, large N-terminal luminal ectodomain, short 
cytoplasmic tail) ubiquitously expressed in various tissues (including the cells 
of the central nervous system, epithelial cells of various organs, and platelets 
[4]). The function of APP remains unclear despite the fact that due to its 
critical role in the development of AD, APP has for a long time been in the 
APP 
structure and 
function 
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center of attention of a large number of research laboratories worldwide. APP 
resembles glycosylated surface receptors [5], has been shown to interact with 
the G0 subunit of the trimeric G proteins [6], to play a role in cell adhesion [7], 
and to function in axonal vesicular transport via the interaction of the 
cytoplasmic domain with the kinesin lightchain [8], gene regulation, cell 
motility/neuritic outgrowth, and synapse formation [9]. 
APP localizes both to the plasma membrane and to intracellular membrane 
compartments. After synthesis in the endoplasmic reticulum (ER), on its way 
to the plasma membrane (PM), APP is subjected to further post-translational 
modifications (N- and O-glycosylation, tyrosine sulfation, and formation of 
disulfide bridges within its ectodomain). While in neurons, APP is present in 
two pools, one of the pools present in all membrane compartments of the 
secretory, endocytic, and lysosomal pathways, and the other highly enriched in 
axons [10, 11], when expressed in polarized epithelial cells, most of the APP is 
sorted to the basolateral domain [12]. Thanks to the endosomal targeting motif 
(YENPTY) within its cytoplasmic tail, APP enters the endocytic pathway via  
clathrin coated pits [13,12],  or by other, dynamin-dependent  and putatively 
raft-mediated routes [14,15]. Like many surface receptors, APP undergoes 
continued recycling and trafficking [reviewed in 16] throughout its lifetime. The 
half-life of APP is however relatively short (around 30 minutes) [18,19]. APP is 
degraded in lysosomes, owing to its GY motif within its cytosolic tail [17].  A 
phenomenon contributing to the relatively short half-life of APP is its 
proteolytic processing, including the ectodomain shedding, which is generally 
an important way of regulating activity of membrane proteins [20,21], and the 
regulated intramembrane cleavage (RIP) of the remaining membrane-
embedded C-terminal stub. 
Proteolytic cleavage of APP and endocytosis of the remaining full-length APP 
together provide for the rapid removal of the cell-surface APP. The estimated 
half-life for surface-expressed APP is indeed less than ten minutes [22], and 
thus only minor amounts of the holo-APP (as compared to the total cellular 
pool) are detected at the plasma membrane [23,24]. 
Enzymes that proteolytically process APP or its fragments are referred to as 
˝secretases˝. Proteolytical processing is necessary for APP to accomplish its 
physiological functions. Secretion of the APP ectodomain (sometimes referred 
to as soluble APP, or APPs) is required to fulfill its biological functions in 
growth regulation and neuroprotection, and, in the case of forms containing the 
APP 
localization 
and 
trafficking  
APP 
processing  
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Kunitz proteinase inhibitor (KPI) domain•, in blood coagulation [25]. Release 
of the intracellular domain of APP by RIP is essential for it to participate in 
intracellular signaling and gene regulation♦. 
The full-length APP is a substrate for two major secretase activities. These 
two competing secretase activities, designated  α and β, are responsible for 
ectodomain shedding of APP, which is a key regulatory step in the generation 
of the Aβ peptide. After reaching the plasma membrane,  a fraction of APP is 
cleaved by either  α- or β-secretases (ectodomain shedding), but the majority 
remains intact and is rapidly internalized. Another portion of the internalized 
pool of APP is cleaved (supposedly mainly by β-secretase), and some of the 
APP is then recycled back to the cell surface, while the rest is delivered to 
lysosomes for degradation. It follows that regulation of trafficking of APP will 
have profound effect on its processing. While the α-secretase activity is present 
mostly at the cell surface, the major location for the β-secretase activity is less 
clear. It appears that, to a certain extent, the β-cleavage can take place in any 
of the membrane compartments mentioned above (plasma membrane, 
endocytic compartments, Golgi/TGN, or perhaps even already in the ER), but 
the major site for β-cleavage cleavage is not known. After the ectodomain had 
been shed, the remaining membrane-anchored portion of the protein is a 
substrate for another secretase activity, γ, which is responsible for the 
intramembrane cleavage.  
To make out this seemingly complicated scheme: there are 3 secretase activities 
that make up 2 possible, competing, mutually exclusive, proteolytical pathways 
for APP: αγ, and βγ    (Figure 1). 
                                                
• Several isoforms of APP exist; the 3 major ones are of lengths 695, 750, and 770 residues 
that arise from alternative splicing. The two longer ones contain the KPI domain, and are 
common in peripheral tissues. In neurons, the 695 amino acids long form is prevailing. 
♦ In fact, a definitive proof for the possibility that the AICD generated by RIP is involved in 
intracellular signaling and gene regulation is missing.  
Ectodomain 
shedding: α-
versus β-
processing  
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Figure 1 Proteolytic processing of APP in cells. Panel A, APP is a target for at least three 
scretase activities, that may generate neurotoxic amyloidogenic species. Panel B, The two 
mutually exclusive proteolytic pathways are depicted. The majority of APP is cleaved by an  
α-secretase in the middle of the Aβ-sequence, and consequently the γ-cleavage releases the 
APP intracellular domain (AICD) along with the so-called p3 peptide (non-amyloidogenic). 
A minor part of the APP pool is cleaved by the β-secretase (BACE), triggering the Aβ 
generation, which is completed upon the γ-cleavage of the C99 C-terminal fragment.  
The major proteolytic pathway, undertaken by ˜95% of the APP in neurons, 
and also a main pathway in non-neuronal cells, is the α - γ pathway, i.e. APP 
is first cleaved by an α-secretase♦. Importantly, the site of this α-cleavage is 
located within the Aβ region, in other words, the α-cleavage precludes the 
formation of the Aβ peptide. Consequently, the remaining membrane-spanning 
fragment is processed by the γ-secretase complex, leading to the release of the 
non-toxic p3 peptide. 
It appears that there is more than one protein with  α-secretase activity. 
Several members of the ˝a disintegrin and metalloprotease˝ domain family 
(ADAM, a large protein family of zinc metalloproteases involved in cell-cell 
interactions and processing of membrane anchored proteins such as TNFα, 
Notch, Delta and others) have been implicated in  α-processing, including 
ADAM9 and ADAM10. Also TACE (ADAM17) [reviewed in 26], which cleaves 
TNFα, seems to be in addition involved in regulatory α-processing of APP in 
fibroblasts [27]. 
                                                
♦  α-secretase ectodomain shedding is analogous to the processing of a series of other integral 
membrane proteins like the transforming growth factor TGFα, tumor necrosis factor TNFα, 
the cell adhesion molecule L-selectin, or the growth factor co-receptor syndecan in that the 
processing consists of a constitutive component and a regulated component that can be 
activated via protein kinase C (PKC) and by other second messenger cascades. 
α-cleavage 
is the major 
cleavage  
Proteins with 
α-secretase 
activity  
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APP that escapes the  α-cleavage gets a chance to enter the alternative 
proteolytic pathway (the β - γ pathway), which leads to the formation of Aβ. 
In this case, APP is first cleaved by the β-secretase (BACE, beta-site amyloid 
cleaving enzyme♣,
 [33]) to allow further processing by the γ-secretase to finally 
produce the 39 to 43 amino acids long Aβ peptide. 
The length heterogeneity of the Aβ peptide arises from the heterogeneity of its 
C-terminus, i.e. it is owing to the γ-cleavage, and the longer Aβ species are 
more toxic than the shorter ones owing to their higher hydrophobicity. Thus 
the factors determining the exact location of the γ-cleavage within the APP 
sequence are also of great importance in AD pathology. 
The β-secretase, BACE, is an atypical member of the pepsin family of aspartic 
proteases; unlike pepsin, gastricsin, or rennin, BACE is an integral membrane 
protein similar to APP in its topology. It is a ˜60kDa membrane protein of 
type I, with a relatively bulky ectodomain conferring the active site (two 
conserved aspartyl protease catalytical motifs (DTGS at residues 93—96 and 
DSGT at residues 289—292), a single transmembrane domain, and very short 
cytosolic tail (24 amino acids long). BACE is expressed as a pro-enzyme, with 
a short pro-domain flanked by a RLPR motif, which is cleaved by furin or 
other pro-convertases [28, 29]. However, the pro-peptide of BACE does not 
confer strict zymogen-like properties, but was found to assist in proper folding 
of the protease domain [30]. BACE is N-glycosylated at 4 sites on its 
ectodomain [31] and palmitoylated on 3 cysteine residues (1 within the TM 
segment, 2 within the cytoplasmic tail), the palmitate acyl chains serving as 
additional membrane anchors [31, 32]. The pattern of disulfide bonding within 
its catalytical ectodomain is fundamentally different from the disulfide motif of 
other known aspartic proteases [31], and with respect to the substrate 
preference and inhibitor profile, BACE has been shown to bear little similarity 
to other aspartic proteases [34]. This finding, along with the fact that BACE 
knock-out mice are perfectly viable and healthy [35], implies BACE as a 
promising and interesting drug target for AD treatment.  
The majority of the cellular BACE pool has been shown to locate to the 
Golgi/TGN and endosomal compartments [36] - a di-leucine motif (DDISLLK) 
had been identified within its cytosolic tail [37], and only a fraction of the pool 
is present at the cell surface. Interestingly, when expressed in polarized 
epithelial cells, BACE is sorted to the apical domain [38]. This spatial 
                                                
♣ The β-secretase had been identified by several laboratories almost simultaneously and thus 
different names were given: BACE, Asp2, memapsin 2 
The β-
cleavage 
leads to the 
production of 
Aβ 
BACE, the β-
secretase: 
structure 
BACE, the β-
secretase: 
localization 
and 
trafficking 
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segregation of APP (basolateral) and BACE (apical) was regarded as a 
paradox, and occurrence of β-cleavage in normal physiology was questioned. It 
was initially assumed that under normal conditions, it may be solely the α-
secretase activity providing for APP ectodomain shedding, and that the β-
cleavage of APP may be pathological. Later it was established that both the β-
cleavage and the formation of the Aβ peptide are normal physiological events 
occurring in healthy cells, even though the function of Aβ remains elusive.  
However, it is not clear whether APP is the main substrate for BACE, since 
several other proteins had been identified that are cleaved by BACE: the cell 
adhesion protein P-selectin glycoprotein ligand 1 (PSGL-1) [39], the 
membrane-bound sialyltransferase ST6Gal I [40], the APP-like-proteins APLP-
1 and -2 [41], and supposedly also the low density lipoprotein receptor-related 
protein (LRP) [42]. 
Even though it is not the β-cleavage itself that would per se lead to the plaque 
formation, but rather the misfolding and aggregation of the generated 
Aβpeptide, up-regulation of the β-secretase activity (as well as down-
regulation of  α-secretase activity) is an issue in amyloidogenesis. Hence it is 
necessary to establish how is the access of the secretases to APP regulated, and 
how are the proteolytic activities of the individual secretases modulated. 
A simple and efficient way of regulating proteolysis (enzymatic reaction) relies 
on limited access of the protease (enzyme) to its substrate. 
One obvious way of restricting a contact between two different membrane 
proteins is by confining them into distinct cellular compartments, and/or 
possibly dispatching them to separate trafficking routes. To a certain extent, 
the access of BACE and other secretases to APP is limited in this way (both 
APP and BACE cycle between the cell surface and intracellular membrane 
compartments). Since trafficking largely relies on interacting proteins 
responsible for sorting, modifying (e.g. phosphorylation) and ˝packing˝ of the 
cargo, these proteins are also candidates for involvement in β-cleavage 
regulation [39, 44]. Such proteins that are part of the cellular trafficking 
machinery interact with sorting motifs within the C-terminal cytosolic tail of 
APP and BACE. The basolateral sorting signal (YTSI) of APP recruits the 
microtubule-binding protein PAT-1 [45] and the YENTPY motif mediates 
interactions with at least three families of adaptor proteins: Fe65, X11, and 
mDAB1 [39].  
The cytosolic domain of BACE contains an acid cluster dileucine motif 
(ACDL) that binds the VHS (Vps-27, Hrs, and STAM) domain of Golgi-
α- versus β-
cleavage: 
how to 
regulate 
them? 
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localized, gamma-ear-containing, Arf-binding proteins (GGA) proteins [46]. 
GGA proteins  were reported to colocalize in the trans-Golgi network and 
endosomes with BACE and a BACE chimera containing a cytosolic domain of 
a mannose-6-phosphate receptor. Depleting cellular GGA proteins with RNA 
interference or mutation of serine 498 to stop the phosphorylation of ACDL 
resulted in the accumulation of BACE in early endosomes, indicating that 
GGAs function in BACE recycling from endosomes to TGN and back to the 
surface.  
Although APP and BACE use different trafficking routes, certain fractions 
reside at any given timepoint within the same membrane compartment. 
Nevertheless, even within the plane of the same membrane (for example 
plasma membrane, early endosomal vesicle), a contact between two different 
membrane proteins (APP and BACE) can be limited by differential 
partitioning into distinct membrane microdomains, such as lipid rafts [47]. 
Partitioning of specific lipids and membrane proteins into functional membrane 
microdomains that may in this way serve as platforms for segregation, sorting, 
trafficking and localized functioning of membrane components, has become a 
widely studied subject and appears to be a promising concept underlying 
numerous processes of cell physiology. 
In the past few years, the more than 30 years old fluid mosaic model [48] had 
been repeatedly challenged and put under scrutiny; the key question can be 
phrased laconically  “whether the membrane may be more mosaic than fluid 
after all“ [this question has been phrased before and discussed for example in 
[49,50]. The efforts aim to extend the fluid mosaic model rather than to reject 
or contradict it. 
The structure of biological membranes has been studied in different contexts 
for years. While in the 70‘s and 80‘s most of the attention had been dedicated 
to proteins, and lipids were regarded mostly as a fluid medium facilitating 
protein diffusion, in the past 15 years the interest has been transferred to 
lipids. (Bio)physicists had realized a long time ago that, regardless of the 
presence of a huge amount of embedded and associated proteins, biological 
membranes are, in the first place, lipid bilayers. Thus, different aspects 
concerning the very essence of lipid bilayers (fluidity, shape/curvature, lateral 
diffusion of lipids and proteins, phase separation) have been studied from the 
physical point of view on model systems and in silico in detail for years. What 
these theoretical studies have in common are the typical “bugs“ characteristic 
to most physical studies - (over)simplification (as a rule, membranes were 
The fluid 
mosaic 
model of the 
plasma 
membrane – 
is it fluid or 
mosaic in 
the first 
place? 
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reduced to phosphatidylcholine membranes, or PC/cholesterol in the best 
cases, and recently also ternary mixtures have been considered (typically 
PC/cholesterol/SM)), extremely strict or drastic, ˝artificial˝, assumptions 
sometimes bordering on absurdity (equilibrium state, assuming all molecules to 
be inert and not interacting with each other, overlooking the protein 
component as insignificant, even though biological membranes contain about 
50% of proteins by weight), ignorance of the vertical asymmetry of the 
membrane, and other. Despite these limitations, model membranes and 
theoretical modeling eventually started to slowly find their way to integrate 
into biological concepts that were being formulated based on mostly 
descriptive, protein-oriented work. The composite picture of membranes as 
physically characterized, biologically functional environment was (and still is) 
lacking. 
The biological world has been becoming increasingly aware of the results of the 
physical and theoretical studies, which seemed to have the potential to 
elucidate some of the poorly understood mechanisms that control localization, 
multimerization, and assembly of membrane proteins and specific lipids in the 
plasma membrane, and thus underlie cell-biological events like signaling, 
vesicular trafficking, protein and lipid sorting. Specialized membrane domains 
such as coated pits, synapses, and cell-adhesion  structures, or caveolae had 
been long known and described, yet the potential of different membrane lipids 
to participate in shaping and functioning of such domains remained 
unrecognized. Such  phenomena that biologists observed but could not fully 
understand demanded introduction of a new concept that would extend the 
original idea regarding the membrane as a homogenous solvent∗. 
Using model membranes, it was found that domains in separate phases, termed 
liquid-ordered (lo) and liquid-disordered (ld), can co-exist within the plane of 
the same membrane•. This finding has eventually lead to the realization that 
                                                
∗ In fact, the original Singer and Nicholson (1972) fluid mosaic model, although emphasizing 
the fluidity, is compatible with the concept of the fluid bilayer accommodating small (100nm 
or smaller) subdomains; however, even though studies considering the possibility of existence 
of small domains in biological membranes periodically appeared, these were generally rather 
abstract, and biological significance of lipid-driven domain formation was not addressed;  
interesting papers appeared already in late ‘70 and ‘80 arguing for the existence of domains 
with different lipid compositions in the plasma membrane of cultured cells [Jain MK, White 
HB (1977) Adv Lipid Res 15, 1-60, Klausner, RD, Kleinfeld AM, Hoover RL, and Karnovsky 
MJ (1980) J Biol Chemistry 255, 1286-1295] 
• The liquid-ordered phase was defined in theoretical work based on five different ex-
perimentally determined phase diagrams for DPPC cholesterol [Ipsen, J. H. , Karlstrom, G. , 
Mouritsen, O. G. , Wennerstrom, H. & Zuckermann, M. J. (1987) Biochim. Biophys. Acta 
905, 162-172]. Recently,  phase diagram for a more physiologically relevant lipid mixture, 
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also biological membranes may be laterally compartmentalized independently 
of the protein component and/or cytoskeleton# owing to lipid phase separation 
and/or preferential interactions of certain lipid species; this idea is the bedrock 
of the raft hypothesis.  
The liquid-ordered phase, the raft phase, requires sterols to form and is 
characterized by tight lipid acyl chain packing, but rapid lateral diffusion of 
individual lipid molecules. Lipid rafts are extremely dynamic and at a steady 
state very small, under the detection limit of microscopy techniques. It is 
however assumed that rafts can be clustered to form larger and more stable 
(longer lasting) assemblies. 
Rafts had been conceptually included in numerous processes at the cell 
membranes that require dynamical segregation of proteins or lipids.  
Indeed, rafts had also been implicated in APP processing [51]. Decreased levels 
of cholesterol and sphingolipids, both of which are indispensable constituents of 
lipid rafts, correlate with reduced β-cleavage [51], while exogenously added 
cholesterol seems to decrease  α-cleavage [52]; also ceramides, which have been 
suggested to play a role in subdomain organization and raft coalescence, were 
proposed as β-cleavage modulators [53]. Besides, mutant BACE linked to a 
GPI anchor, which enhances its association with detergent resistant 
membranes♥ (DRMs), seems to cleave APP more efficiently than the wild type 
BACE [54]. 
                                                                                                                                     
namely POPC/SM/cholesterol, which resembles the composition of DRMs, was published [de 
Almeida RF, Fedorov A, Prieto M (2003) Biophys J 85, 2406-16]. Looking at this phase 
diagram (not shown here), one can recognize the function of cholesterol as a fluidity 
modulator: 
Adapted from Munro, S. Cell (2003)
(So)
cholesterol
Raft-like phase
cholesterol
 
Depending on the composition, increasing cholesterol content may either render the bilayer 
more fluid (for example, moving from single phase (lo) composition of 30:10:60 down along 
the decreasing cholesterol content we arrive at ld+lo coexistence region), or more ordered 
(increasing cholesterol content at the expense of POPC in a mixture of POPC:SM 20:80 
which exists in a gel state, we arrive at a lo+so coexistence region, for example 10:80:10). 
# domains dependent on protein components or underlying cytoskeleton had been recognized 
before (caveolae, coated pits) 
♥ DRMs - detergent resistant membranes; DRMs represent a fraction of membranes (ie lipid 
membranes and associated proteins) that are insoluble in Triton X-100 at 4oC. DRMs were 
initially often mistakenly identified with lipid rafts. The discovery of the detergent-insoluble 
fraction of the membranes was put in context with the work done on model membranes, 
which revealed that liposomes in the liquid-ordered state are resistant to solubilization with 
non-ionic detergents [Schroeder R, London E, Brown D. (1994) Proc. Natl. Acad. Sci. USA  
91, 12130-34]. Apical domains composed of glycosphingolipids and a specific subset of 
proteins including the GPI-anchored proteins were hypothesized in polarized epithelial cells 
Implication 
of rafts in 
APP 
processing 
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Mechanistically, rafts could be involved in β-secretase activity regulation in at 
least three ways: 1. ˝trapping˝ APP/BACE and confining them to the 
relatively small area of the (short-lived) lipid raft would lead to a drastic 
increase in local concentration, 2. facilitating delivery of APP/BACE to a 
cellular compartment where the β-cleavage predominantly happens (supposedly 
early and recycling endosomes), 3. offering an environment (characterized by 
its lipid composition different from the bulk rest of the membrane) that 
presents optimal conditions for cleavage (for example supplying necessary lipid 
cofactors or co-structures (hypothetical) or providing optimal fluidity). 
There is a large body of experimental work done on cells in culture as well as 
ex vivo concerning partitioning of APP and BACE into DRMs [55, 56, 57, 58]. 
Despite the usefulness of probing DRM association in early stages of 
characterization of the proteins, and especially for detecting changes in 
interactions of membrane components, this type of experimental approach 
cannot provide adequate insight into raft connections to APP processing. 
When APP and BACE are tested for raft association by antibody cross-
linking♠, they copatch with a raft marker PLAP but clearly segregate from a 
                                                                                                                                     
[Simons K, and van Meer G. (1988) Biochemistry 27, 6197-6202, and Simons K, and van 
Meer G. (1988) J Cell Biol 36, 51-58], and when it was later revealed that a Triton X-100 
insoluble membrane fraction from mammalian cells was enriched in GPI-anchored proteins, 
sphingolipids, and cholesterol, it was suggested that this DRM fraction represents an actual 
subset of membrane domains existing in living cells; various lines of experimental studies 
eventually converged in the raft hypothesis. It was however soon established that DRMs, 
defining a fraction of membrane components that behave in a particular way upon a drastic, 
invasive treatment of the native membrane, cannot be identified with pre-existing domains. 
Thus it is necessary to emphasize that DRMs are not rafts, but that the fact that a protein 
is found within the DRM fraction merely indicates its increased tendency to associate with 
liquid ordered phase rather than to dissolve in Triton X-100 micelles, but does not 
necessarily implicate its partitioning into the lo phase (raft phase) in the intact, unperturbed 
native membranes.    
♠ Cross-linking refers to binding of a multivalent ligand specifically recognizing a certain 
molecule or a group of molecules bearing a common binding motif/moiety (for example 
glycosylation). Such cross-linking is somewhat similar to multimerization. Cross-linking of 
raft components is believed to lead to stabilization of raft domains. Cross-linking is 
schematically depicted in the figure below. When raft components (components strongly 
associating with the raft phase are depicted in dark red, less raftophilic molecules in bright 
red; non-raft components are blue; soluble cross-linkers are depicted in bright orange) are 
˝dragged together˝ in this way, they take their surrounding liquid-ordered lipid microdomain 
(depicted in darker grey) along. Thus, multimerization/cross-linking of  raft-associated 
molecules leads to raft clustering, which can eventually lead to domain coalescence: 
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non-raft marker (transferrin receptor) and APP and BACE could also be 
induced to copatch with each other upon cross-linking [51]. 
These findings indicate that rafts may be involved in regulation of APP 
cleavage as reaction platforms,  but in addition, β-secretase activity is likely to 
be regulated by direct modulation of the enzymatic activity of BACE. One 
such regulatory factor is the pH of the surrounding aqueous environment; 
another mechanism engages membrane lipids, either directly interacting with 
BACE as cofactors or co-structures, or simply providing optimal bulk 
membrane properties.  We had therefore set about to characterize the lipid 
requirements for β-cleavage in an artificial, reconstituted system composed of 
purified proteins and defined lipids. Our data demonstrate that lipids are 
involved in regulating β-secretase activity of BACE. 
Possibilities to manipulate lipid composition of the cell membranes are limited, 
and often do not deliver clear-cut results either, since the risk of secondary 
effects is high. Since rafts are sensitive to cholesterol and sphingolipids levels, 
manipulating content of these lipids in living cells counts as a useful approach 
to address raft fuction, but especially cholesterol depletion with methyl-β-
                                                                                                                                     
 
Domain clustering and coalescence
Binding of multivalent ligands (cross-linking)
 
Owing to the fact that cross-linking of raft-associated molecules causes translocation of the 
whole domain (lipids and associated proteins), cross-linking of one species may lead to co-
clustering of multiple raft components. When antibodies against two different raft-associated 
proteins are simultaneously used for cross-linking, this leads to their concurrent translocation 
and results in co-clustering, which is observed as strong co-localization in membrane patches. 
This is referred to as ˝patching˝ and ˝co-patching˝[Harder T, Sheiffele P, Verkade P, and 
Simons K (1998) J Cell Biol 141, 929]. Co-patching is an additional way (besides DRM 
isolation) to operationally define raft-components. In contrast, cross-linking of non-raft 
components leads to generation of homogenous assemblies of the cross-linked species. 
The concept of cross-linking originates from the observation that extracellularly exposed 
lipids and membrane proteins can be laterally cross-linked with specific antibodies or 
multivalent bacterial toxins, causing a redistribution of these plasma membrane elements 
which tend to form patches on the cell surface [Spiegel, S., S. Kassis, M. Wilchek, and P.H. 
Fishman (1984) J Cell Biol 99, 1575]. Later, the finding that  multimerization of GPI-
anchored proteins regulates signalling and affects their segregation in caveolae [Mayor S, 
Rothberg KG, Maxfield FR. (1994) Science 264, 1948-51] contributed to experimental 
interest in using cross-linking as a means of exploring lipid domain organization of the 
plasma membrane. 
Looking at 
membrane 
lipid 
functions in 
cells 
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cyclodextrin was shown to cause serious side-effects (disruption of the SNARE 
clusters required for exocytosis [59], block of the clathrin-coated pit formation 
[60, 61], phosphatidylinositol(4,5)-bisphosphate delocalization from the plasma 
membrane [62]). 
Due to these limitations characteristic for working with living cells, it appears 
often useful to transfer the studied system to an artificial setup. Membrane 
proteins can be isolated and purified, and reconstituted in artifical membranes.  
Reconstituting membrane proteins in artificial bilayer systems (supported 
membranes or free-standing membranes, like liposomes) offers the advantage of 
having a full control over the lipid composition of the membrane (actually, 
over the overall composition of the bilayer; unfortunately we are not yet able 
to control composition of the two leaflets separately). A number of membrane 
proteins have been isolated and consequently reconstituted into 
proteoliposomes in a functional state, including both bacterial and eukaryotic 
membrane proteins. Such studies provide valuable insights into how membrane 
lipids influence activity of membrane proteins via directly interacting with 
them (best known examples include the interaction of GM3 ganglioside with 
the epidermal growth factor receptor [63],[64], or the chaperone-like function of 
phosphatidylethanolamine in the assembly of bacterial lactose permease [65]), 
owing to the collective physico-chemical properties characteristic for the 
particular lipid composition (typical example of such effect are interactions of 
peripheral  membrane proteins with negatively charged lipid species at the 
cytoplasmic leaflet of the membrane, or influence of fluidity or bilayer 
thickness on the activity, for example for (Ca2+ + Mg2+)-dependent ATPase 
[66]), or both (more often than not it is difficult to distinguish between the 
bulk effect and specific effect). However, despite such, however impressive, 
achievements in the field of membrane protein structure and function♣ and 
lipid interactions, approaching membrane protein structure and function in 
context of lateral domain organization of the membrane has not yet become a 
challenge for the mainstream research.   Essentially all the studies addressing 
the issue of possible requirements of particular membrane lipids for folding, 
activity, or trafficking of membrane proteins have been focusing on 
characterizing these interactions in context of the entire pool of the particular 
protein and the overall, average lipid composition of the membrane.  Hence the 
resulting picture will, most likely, fail to reveal the possible existence of 
                                                
♣ the number of solved structures of membrane proteins is increasing 
[http://blanco.biomol.uci.edu/Membrane˙Proteins˙xtal.html] 
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different pools of the particular protein, each present within its own membrane 
environment and thus subject to distinct lipid(or protein)-mediated 
modulation, independent of the average, exceedingly complex, composition of 
the membrane. In order to unravel the principles and a rationale behind this 
enormous, puzzling complexity, characteristic for all biomembranes, the aspect 
of domain-dependent regulation of membrane-associated processes needs to be 
addressed. Easily said, yet difficult to tackle experimentally. While an 
enormous number of papers descriptively implicating lo domains - rafts - in 
various physiological processes have been published in last 10 years, the way in 
which these functional subdomain compartments mechanistically 
affect/facilitate membrane protein interactions in (model) membranes had not 
yet been thoroughly experimentally explored. Only sporadically studies 
pointing somewhat in this direction emerge [67, 68]. An interesting in silico 
study analyzing the size restrictions posed on microdomains to allow them to 
deliver an effect on promoting protein-protein interactions was published 
recently [69]. 
It is obvious that our toolbox for membrane, and raft, studies has to be 
updated and expanded in order to match the current needs. One such 
relatively new, promising tool are the giant unilamellar vesicles that are 
suitable for studies with reconstituted membrane proteins via employing 
advanced spectroscopic and microscopic methods [94]. Thanks to the increasing 
number of studies characterizing phase separation in model lipid mixtures 
[90,88,93,95], it is possible to achieve micron-scale phase separation in model 
membranes, and observe these co-existing phases AND the co-existing pools of 
proteins partitioning into the different phases in GUVs [71].  
While GUVs are already becoming a standard tool to study phase separation, 
membrane curvature effects, and partitioning of membrane proteins, employing 
GUVs in studies aiming to find a link between phase separation and regulation 
of activities of associated membrane proteins seems to be untested. Hopefully, 
work presented in this thesis will contribute to promoting such experimental 
approaches. 
The general aim of the project underlying this thesis is to characterize how 
lipids may be involved in modulating β-secretase activity of BACE. Since 
membrane protein activity may be linked to the lipid composition of the 
bilayer in different ways, this formulation is rather vague and hard to pursue. 
Hence individual aspects of lipid-dependent regulation were addressed 
Aim of the 
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A promising 
tool for 
studying 
domain-
related 
properties of 
membrane 
proteins: 
GUVs 
Introduction  21 
Lucie Kalvodova  Lipid requirements for β-secretase activity of BACE 
separately: First, which membrane lipids influence♣ the proteolytic activity of 
BACE, irrespectively of the presence of membrane-anchored full-length APP. 
Experiments addressing this issue involved comparing specific activity of 
BACE reconstituted in liposomes of different lipid compositions exerted 
towards a soluble peptide substrate. Second, partitioning preferences of BACE 
and APP in systems with co-existing liquid-ordered (lo) and liquid-disordered 
(ld) phases were examined; for this purpose, the proteins were reconstituted in 
giant unilamellar vesicles (GUVs) and their association with lo and ld phases 
was probed microscopically and by fluorescence correlation spectroscopy. Third 
and most important, APP and BACE were co-reconstituted together in 
liposomes to tackle a question analogous to the first one but this time involving 
the full-length APP as a substrate. The ultimate goal is not only to identify 
lipids or lipid compositions that influence β-cleavage of APP, but also to 
uncover the underlying mechanism, and especially to explore the impact of 
membrane domain organization/phase coexistence on the APP and BACE 
interaction. 
                                                
♣ already in this simple case, without APP as a substrate, two different modes of action can 
be postulated for lipid influence. First, direct interaction of a specific lipid in the bilayer or 
within a microdomain with a distinct lipid composition providing locally higher 
concentrations of particular lipids; a specific lipid may bind/interact with BACE and thus 
stimulate/diminish its activity. Second, lipid compostition providing for average ˝bulk˝ 
properties of the membrane  or of the membrane microdomain like fluidity, curavature, 
hydrophobic thickness, surface charge and other, which in their end-effect influence BACE 
conformation and thus activity. 
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3. Materials and methods 
3.1. Materials 
3.1.1. Reagents and chemicals 
Lipids 
Lipids were purchased from Avanti Polar Lipids as chloroform solutions or in 
powder form, and were used without further purification. Gangliosides, PC, 
PE, PS, and cerebrosides were from porcine brain, while PA was from egg PC, 
and PI from bovine liver. POPC and DOPC were synthetic. 
Detergents 
Triton X-100 was from Fluka; C12E8, decylmaltoside (DM), dodecylmaltoside 
(DDM), octylglucoside (OG) and HEGA10 detergents were acquired from 
Anatrace, cholate, deoxycholate, and SDS from Sigma. 
Resins for affinity purification 
Both IgG Sepharose 6 Fast Flow and Glutathion Sepharose beads were 
purchased from Amersham Biosciences. 
Fluorescent reagents 
The amino-reactive dye CY5 was purchased from Amersham Biosciences. DiO 
fluorescent lipid analog (3,3’-dioctadecyloxacarbocyanine perchlorate (’DiO’; 
DiOC18), Alexa488-cholera toxin subunit B conjugate, and amino-reactive 
Alexa488 dye were all from Molecular Probes. 
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Antibodies 
Rabbit polyclonal antibody 7523 against BACE ectodomain was a kind gift 
from Christian Haass. Mouse monoclonal antibody 6E10 against aa 1-5 of Aβ  
was purchased from Signet, and β-cleaved-ectodomain-specific antibody ANGU 
was a gift from Patrick Keller. 22C11 mouse monoclonal antibody against 
reduced denatured APP was from Chemicon. The detection antibodies used for 
the MSD assay are proprietary to Meso Scale Discovery (Meso Scale 
Diagnostics, LLC). 
Other reagents and materials 
OptiPrep density gradient media was from Axis-Shield (Oslo, Norway). Cell-
culture media and the NuPAGE 4-12% BisTris gels were from Invitrogen. All 
other chemicals were from Sigma and Merck. The recombinant human BACE 
ectodomain was from Oncogene, and the fluorogenic soluble peptide substrate 
for BACE (FS-1, Arg-Glu(EDANS)-(Asn670,Leu671)-Amyloid β/A4 Protein 
Precursor 770 (668-675)-Lys(DABCYL)-Arg) was purchased from Bachem.  
3.1.2. Cells, constructs, and viruses 
The Spodoptera frugiperda suspension cell line SF+ was from Protein Sciences. 
All constructs and viruses were derived from the pFastBac vector, which is a 
part of the baculovirus expression system supplied by Invitrogen. 
3.1.3. Equipment 
Centrifuges and rotors 
Beckman Optima Max (Beckman Coulter) tabletop centrifuge was used with 
rotors TLA45 and TLS55. 
Beckman XL-100k Ultracentrifuge (Beckman Coulter) was used with Type 
45Ti and SW60 rotors. 
Other equipment 
Miniextruder used for LUV preparation was from Avanti Polar Lipids, and 
protein electrophoresis apparatus X-cell Sure Lock from Invitrogen. 
Fluorescence-based assays in multiwell format were performed using Ascent 
Fluoroskan CF platereader. 
Confocal fluorescence microscopy and FCS were performed on a commercial 
ConfoCor2 (Zeiss, Jena, Germany) system. 
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For the MSD assay, Sector Image Reader 6000 along with Discovery 
Workbench software was used (MSD Discovery).  
3.2. Methods 
3.2.1. Constructs, primers, and baculovirus 
generation 
Human wt BACE1a was amplified by PCR with primers introducing NcoI 
(containing initial ATG) site at the 5‘ 
(CGTAGGCCATGGCCCAAGCCCTGCCCTGGCTC) end and XhoI at the 3‘ 
end 
(GGAATTCTTAGCTCGAGCCCTTAAGCAGGGAGATGTCATCAGC).  
Human wt APP695 was amplified by PCR with primers introducing NcoI 
(containing initial ATG) site at the 5‘ 
(CGTAGGCCATGGGTCTGCCCGGTTTGGCACTG) end and XhoI at the 
3‘ end 
(GCTCTAGATTAGCTCGAGCCGTTCTGCATCTGCTCAAAGAACTTGT
A). 
In constructs used for purification of APP and BACE, APP/BACE were fused 
to a C-terminal TAP tag via a protease-resistant linker of the sequence 
(SSGPSGS) followed by the PreScission protease cleavage site (LEVLFQ*GP). 
The overall modular structure of the construct was thus (APP or BACE)-
linker-PreScission-TAP, which was cloned into the pFastBac vector 
(Invitrogen) under the control of the polyhedrin promoter. 
The recombinant baculovirus was generated according to the manufacturer‘s 
instructions. 
3.2.2. BACE expression and purification 
All buffers used throughout the procedure were based on 50mM HEPES pH 
7.25, 150mM NaCl (HBS). 
The SF+ (Protein Sciences) cells were grown in suspension in a serum-free 
medium (SF900 II SFM) at 27oC, and were infected with the recombinant 
baculovirus at the cell density of 1.5x106 cells/mL. The virus stock was roughly 
titrated by expression levels as judged from western blotting. Cells were 
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collected by centrifugation (30 min, 400g) 48 hours post infection, and frozen 
and stored at -80oC. 
APP and BACE were purified from isolated membranes of the collected cells. 
Cells were homogenized in presence of protease inhibitors (chymostatin 6 
µg/ml, leupeptin 0.5  µg/ml, antipain 10  µg/ml, aprotinin 2  µl/ml, pepstatin 0.7 
µg/ml, APMSF 10µg/ml, and E64 0.1mM) in HBS buffer containing 0.25M 
sucrose in a hand-held glass homogeniser (20-30 strokes). The homogenate was 
centrifuged at ˜100,000g for 45min at 4oC. The supernatant was removed, and 
the resulting pellet was resuspended with the help of the glass homogeniser in 
HBS + 1% w/v dodecylmaltoside, supplemented with protease inhibitors. The 
lysate was incubated at room temperature with stirring for ˜ 30min, followed 
by centrifugation at ˜100,000g for 45min at 4°C. The resulting supernatant was 
immediately loaded on an equilibrated IgG Sepharose column (1.5mL beads for 
1L cell culture) and washed with 10 column volumes (cv) of the running buffer 
(RB) (HBS + 5% glycerol, 0.5% w/v Triton X-100, pH 7.6), 1 cv RB + 5mM 
ATP, 2 cv RB, 2 cv RB 2mM EDTA, and finally 5cv RB, usually with reduced 
detergent content (as little as 0.05% Triton X-100 is sufficient for BACE, while 
for elution of APP, 0.5% is required; 0.1% Brij35 proved to be a good 
alternative though). The flow was then stopped and ˜150µl of the PreScission 
protease (0.5mg/mL) was added to the beads, mixed, and incubated either 3-4 
hours at room temperature or 12-16 hours at 4oC. The tagless protein was then 
eluted at a concentration of 0.25 - 0.8 mg/mL with RB supplemented with 10-
50% glycerol. In order to remove the PreScission protease (GST-tagged), the 
eluate was incubated with glutathion transferase beads for ˜ 30 minutes, and 
the beads were removed by centrifugation. Purified BACE proved to be stable, 
and was stored at 4oC, or mixed with 50% glycerol and stored at -20°C, or 
frozen in liquid nitrogen for long-term storage. In contrast, purified APP 
quickly degrades at 4oC and was therefore stored with 50% glycerol in -20oC  or 
in liquid nitrogen in small aliquots. 
3.2.3. Preparation of large unilamellar vesicles 
(LUVs) 
Large unilamellar vesicles were prepared from a hydrated suspension of 
multilamellar vesicles by extrusion. Briefly, lipids were mixed in chloroform in 
a borosilicate glass test-tube, and the solvent was evaporated under a stream of 
nitrogen for ˜1 hour. The dry lipid film (which was consequently left under 
vacuum when the original volume of organic solvent was greater than 200µl) 
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was then hydrated with the LUV buffer (50mM HEPES, 150mM NaCl, 0.2mM 
EDTA, pH 7.25), which was preheated to/above of Tm of the lipid mixture. 
Hydration was carried out at/above the Tm with occasional vortexing for at 
least 30min, or until the suspension appeared homogenous. The resulting 
suspension was subjected to 3-4 freeze-thaw cycles, and finally extruded 
through 100nm pore diameter polycarbonate membrane using the Avanti mini-
extruder. 
3.2.4. Reconstitution of APP and BACE to form 
proteoliposomes 
Typically, LUVs were diluted to ˜1mg/ml, and the detergent (HEGA10 for 
BACE, OG for APP and APP/BACE co-reconstitutions) was added to the 
final concentration corresponding to the ˝onset of solubilization˝ [70], which 
was determined by turbidity measurements. Typically, this value would be ˜ 
0.26% w/v HEGA10 and 0.6% OG, differing slightly for each lipid mix. The 
liposomes were then incubated for 10min at RT to allow the detergent to 
equilibrate between the aqueous phase and the liposomes, and consequently, 
concentrated BACE (typically 0.35mg/ml in 0.3% Triton X-100 and 50% 
glycerol) was added at a protein to lipid ratio 1:70 to 1:150 w/w. The Triton 
X-100 concentration was maintained safely below the cmc (typically  below 
0.008%). The mixture was then incubated at 32oC with shaking for 30min, and 
consequently for 5min at RT before loading on a Sephadex G-50 column of 
appropriate dimensions. The size of the column was determined empirically 
using liposomes with HEGA detergent, so that good separation of liposomes 
from HEGA detergent was ensured (as little as 0.01% HEGA can be detected 
using the BCA reagent (unpublished observation)). The proteoliposomes were 
collected (turbid fractions), adjusted to 12-20% iodixanol, and under-layered 
under the 2.5% and 5% iodixanol layers in an ultra-clear tube of an 
appropriate size depending on the final volume. Gradients in 11x34mm tubes 
were centrifuged for 1h15min in the Beckman TLS55 rotor at 52krpm at 4oC; 
alternatively, 11x60mm tubes were centrifuged in the Beckman SW60 rotor for 
3h at 42krpm at 4oC. Proteoliposomes would typically band at the 5%/12% 
interface, or would be dispersed in the 5% layer. Empty liposomes would be 
mostly on the very top of the gradient. 
The band was collected and diluted at least 6-fold with LUV buffer, and the 
proteoliposomes were pelleted for at least 2h, 38krpm, 4oC in the Beckman 
TLA45 rotor. The supernatant was carefully removed, and the pellets were 
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resuspended in LUV buffer and stored on ice for several weeks without 
detectable change in BACE activity; APP-containing liposomes were snap-
frozen in liquid nitrogen for longer storage. 
For APP/BACE co-reconstitution, the method was modified in order to speed 
up the procedure. Buffers of higher pH (8.2) were used, proteoliposomes were 
pelleted on sucrose cushions at 2oC, and the ready proteoliposomes were snap-
frozen in liquid nitrogen in small aliquots immediately. 
3.2.5. Analysis of protein incorporation in 
proteoliposomes 
Determination of BACE and lipid content in proteoliposomes 
An aliquot of the proteoliposomes was loaded on a NuPAGE BisTris 4-12% gel 
along with APP/BACE mass standards, and run in MOPS buffer. The 
concentration was determined by densitometry after silver staining (useful 
range 15-200ng BACE / band, 4-80ng APP). 
If desirable, lipid content was estimated from a TLC plate by comparing with 
appropriate standards. 
Proteinase K treatment of reconstituted proteoliposomes 
Three equivalent samples of proteoliposomes containing 450ng BACE in LUV 
were processed in the same way: 
1. ˝treated˝: proteoliposomes supplied with 10µg of proteinase K 
2. ˝untreated˝: non-digested sample, where proteinase K was omitted, 
to determine maximum possible recovery of the protein 
3. solubilized sample supplied with 0.5% Triton X-100 and 0.45% 
Tween 20♣ for determination of maximum digestion  
Samples were incubated for 1 hour at 37oC, and the reaction was stopped by 
adding 5mM PMSF and placed on ice. Samples were pelleted at 42krpm, 20min 
in TLA45 rotor at 4oC, and supernatants and pellets were analyzed separately 
by western blotting using the 7523 antibody directed against the BACE 
ectodomain. 
                                                
♣ specific activity of proteinase K in 0.5% Triton X-100 + 0.45% Tween 20 is comparable to 
detergent-free conditions (Qiagen product information). 
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Sodium carbonate treatment of proteoliposomes 
Integral membrane proteins are not extracted from the membrane when 
treated with 0.1M Na2CO3 [72]. 
Proteoliposomes were treated with 0.1M Na2CO3, pH 11.3, and floated in 
OptiPrep density gradient (step gradient 40,30,5%) prepared in 0.1M Na2CO3.  
3.2.6. Cholesterol depletion from proteoliposomes  
Proteoliposomes were treated with ˜5mM methyl-β-cyclodextrin for 15min at 
30oC with gentle shaking, and the activity assayed upon 5-fold dilution with 
assay buffer. As a control, BACE in Triton X-100 was treated likewise. 
3.2.7. Activity assays 
In a 96 well plate, typically 12.5ng and 25ng of BACE in proteoliposomes was 
adjusted to 30µl with the LUV buffer, and the reaction was started by adding 
70µl of the reaction buffer (80mM acetate buffer pH 5 supplemented with 
90mM NaCl as an osmotic balancer) premixed with the FS-1 substrate (stock 
solution ˜250mM in 1.5M HAc). The final concentration of FS-1 was ˜8mM, 
which was enough to saturate 200ng of BACE in 0.025% Triton X-100, or 40ng 
of BACE in total brain lipid proteoliposomes. 
The activity was determined from the linear region on the reaction progression 
curve (typically up to 1500s) measured as fluorescence at 485nm, excitation 
355nm, 37oC using the Ascent Fluoroskan CF reader. The reaction was 
followed for 4000s in 40s steps, with gentle shaking in between measurements. 
3.2.8. Preparation of GUVs with incorporated 
APP and/or BACE (˝proteo-GUVs˝) 
BACE and APP were labeled with the amino-reacitve (maleimide) dye Cy5 
directly in elution buffer, and the unreacted dye was separated on a Sephadex 
G-50 column. The efficiency of labeling was ˜12 Cy5 fluorophors/APP 
molecule, and ˜2 Cy5 fluorophors/BACE molecule, and specific activity 
remained unchanged. The labeled proteins were reconstituted in LUVs (when 
required, the LUVs were prepared with 0.05 - 0.1 mol % DiO) following the 
same procedure as with non-labeled proteins, except for that the reconstitution 
buffer was of a 10-fold lower ionic strength (5mM HEPES, 15mM NaCl). After 
flotation in an OptiPrep gradient, proteoliposomes (proteo-LUVs) were pelleted 
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(100000g, 1h) and resuspended in milli-Q water containing 10mM trehalose to 
a final lipid concentration of 20 to 50 mM. To form the proteo-GUVs, a 
recently developed reconstitution technique was used [71]. The vesicle 
suspension was deposited onto ITO-coated coverslips and put in the vacuum at 
4oC overnight. During membrane de-hydration at low temperature, the vesicles 
underwent fusion and formed large patches of membranes. Liposomes were re-
hydrated in water or 10mM phosphate buffer (pH 7.2) upon an alternate 
electric field in the flow chamber, as described previously for the GUVs 
preparation. After 3 to 4 h, numerous unilamellar vesicles formed, with a 
diameter varying between 10 and 150µm. In the case of lipid mixtures of high 
phase-transition temperature, membranes were first re-hydrated under the 
electric field at 55oC for 15min and then cooled down for the following 2 to 3 h. 
3.2.9. Confocal fluorescence microscopy and 
Fluorescence Correlation Spectroscopy (FCS) 
(courtesy of Nicoletta Kahya) 
Confocal fluorescence microscopy and FCS were performed on a commercial 
ConfoCor2 (Zeiss, Jena, Germany). Confocal images were taken with the laser 
scanning microscopy (LSM) module. The excitation light of an Ar ion laser at 
488 nm and of a HeNe laser at 633 nm was reflected by a dichroic mirror (HFT 
UV/488/543/633) and focused through a Zeiss C-Apochromat 40x, NA=1.2 
water immersion objective onto the sample. The fluorescence emission was 
recollected by the same objective and split by another dichroic mirror (NFT 
635VIS) into two channels. Detection of the fluorescence emission, after passing 
a 505-530 nm bandpass filter in the first channel and a 560 nm longpass filter 
in the second channel, was obtained with two photomultipliers (PMTs). 
Pinholes (60µm) in front of the PMTs ensured the confocal geometry. FCS 
measurements were performed by epi-illuminating the sample with the 633 nm 
HeNe laser (Iex ≈ 1.2 kW/cm
2). The excitation light was reflected by a dichroic 
mirror (HTF 633) and focused onto the sample by the same objective as for 
the LSM. The fluorescence emission was recollected back and sent to an 
avalanche photodiode via a longpass filter (LP560). Out-of-plane fluorescence 
was reduced by a pinhole (90µm) in front of the detector. The laser focus was 
positioned on the topside/bottomside of GUVs, by performing an axial (z-) 
scan through the membrane prior to the FCS recording. The fluorescence 
temporal signal was recorded and the autocorrelation function G(τ) was 
calculated, according to [73]. The apparatus was calibrated by measuring the 
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known three-dimensional diffusion coefficient of rhodamine in solution. The 
detection area on the focal plane was approximated to a Gaussian profile and 
had a radius of ≈ 0.18µm at 1/e2 relative intensity. Data fitting was performed 
with the Levenberg-Marquardt nonlinear least-squares fit algorithm (ORIGIN, 
OriginLab, Northampton, MA). The fitting equation made use of a two-
dimensional Brownian diffusion model, assuming a Gaussian beam profile: 
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where <Ci> is the two-dimensional time average concentration of the species i 
in the detection area Aeff and τd,i is the average residence time of the species i. 
The diffusion coefficient Di for the species i is proportional to τd,i. For FCS 
measurements, three independent GUVs preparations were analyzed and, for 
each of them, data from at least 20 different GUVs were recorded with 100s 
acquisition time per FCS measurement. When membrane phase separation was 
visualized with the LSM, the laser focus was always positioned onto one phase 
only for the FCS experiment. 
Molecular partition coefficients in lipid phases (gel-to-ld or lo-to-ld) were 
measured by fluorescence intensity analysis of confocal images and by 
measuring the number of molecules in the focal volume by FCS. 
3.2.10. Blue native PAGE (BN-PAGE) 
BN-PAGE was performed essentially as described in [74] using a 4-16% gel. The 
migration of the molecular weight markers is anomalous since the marker that was 
used was a regular commercial unstained SDS-PAGE marker mixture loaded with BN-
PAGE loading buffer. The gel was first extensively washed to remove the dye 
(Coomassie Brilliant Blue G) and then silver stained. 
3.2.11. MSD assay for detection of β-cleaved 
ectodomain of APP 
In this thesis, the name ˝MSD assay˝ refers to multiwell-format 
immunodetection assay based on the technology introduced by Meso Scale 
Discovery. The MSD technology is based on MULTI-ARRAYTM technology, a 
proprietary combination of patterned arrays and electrochemiluminescence 
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detection. The actual setup is somewhat similar to ELISA, however instead of 
the traditional enzyme-linked detection, the MSD assay makes use of the 
unique electrochemiluminescence detection. 
The molecule to be detected is captured by an antibody or other tightly 
binding ligand which had been preadsorbed to the wells of the plate (or to a 
particular spot in case of plates with patterned wells). The detection procedure 
is in principal similar to ELISA up to the actual detection step. The wells are 
washed and incubated with primary and secondary detection antibodies (or 
other ligands). The secondary detection ligand carries the special ruthenium-
containing tag, which upon excitation with electric current generates 
luminescence. The luminescent signal is detected optically and quantified. 
For the detection of the β-cleaved ectodomain of APP, 1 spot of a 4-spot high 
binding 96 well plate was coated with 0.5µl of 100 ng/µl 22C11 antibody in 
150mM NaCl, 20mM Tris.Cl pH 7.6. Plates were dried at RT for 1 hour, and 
consequently blocked with 3% BSA in TBS-T (TBS-T 20mM Tris.Cl, 150mM 
NaCl, 0.05% Tween20, pH 7.6) for at least 1 hour at 4oC. After washing 3x 
with TBS-T, samples were applied in total volume of 25µl and binding was 
allowed to proceed for 1 hour at RT. Consequently, wells were washed 3x with 
TBS-T, and primary antibody (b116) was added for 1 hour. After a brief 
washing step (1 or 2x with TBS-T), wells were incubated with STAG-
streptavidin for 30min. Plates were read using the Sector Imager 6000 Reader 
(MSD Discovery) in MSD-T reading buffer following a thorough wash (4x) 
with TBS-T. All incubation steps were performed with vigorous shaking. 
3.2.12. Electron microscopy 
Samples were dried on a grid, fixed with 2% paraformaldehyde and quenched 
with glycine. For labeling, 7523 (C.Haass) antibody directed against the BACE 
ectodomain or the 6E10 antibody against the Aβ portion of APP were used 
together with 6 or 12nm-gold conjugated secondary antibodies. After labeling, 
samples were fixed as before, washed, and stained with uranyl acetate. 
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4. Results 
4.1. Protein expression and purification 
4.1.1. Overexpression of APP and BACE 
In order to prepare milligram amounts of active human APP and BACE, we 
employed the baculovirus expression system along with the suspension-grown 
insect cell line SF+, which is capable of performing post-translational 
modifications common in mammalian cells (palmitoylation, glycosylation). We 
tested two different promoters: a late promoter (polyhedrin) and immediate 
early promoter (IE1). While the expression under the IE1 promoter only 
yielded protein in detectable quantities (as judged by western blotting) at ˜52 
hrs p.i., and then the expression was shut down, the polyhedrin promoter 
driven expression of APP and BACE was observed over a wider time window, 
between 40 and 74 hrs p.i.(Figure 2). Expression levels were generally higher 
with the polyhedrin promoter-based constructs, and therefore these constructs 
were used for further work.  
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Figure 2 Timecourse of expression of TAP-tagged APP and BACE under the polyhedrin 
and IE1 promoters. 
Panel A Expression of BACE under the control of the late polyhedrin promoter. Cells were 
collected at the timepoints indicated (the last timepont ˝last˝ was collected after 5 days), 
lysed in 0.1% Triton X-100, and centrifuged to separate soluble material from the insoluble 
pellet. Expression was first detected at 52 hrs p.i. After 64 hrs, the expression levels did not 
significantly increase. Panel B Expression of APP under the control of the late polyhedrin 
promoter. Expression was first detected at 40 hrs p.i. and reached maximal levels around 74 
hrs p.i. Panel C Expression of APP under the control of the immediate early promoter1. 
Expression was detected at 52 hrs p.i. Both APP and BACE were detected using HRP-
labelled rabbit-anti-goat antibody (binding to the protein A portion of the TAP tag). 
  
Expression was also observed by immunofluorescence, and efficient plasma-
membrane transport was confirmed (Figure 3). 
 
Figure 3 Immunofluorescence on ConA slides, SF+ cells 
The cells were attached to concanavalin A coated coverslips and viewed in epifluorescence 
setup. Panel A - SF+ cells infected with wt baculovirus, stained with 9E10(anti-myc) 
antibody followed by donkey anti mouse conjug. to CY3 at 10x mag., Panel B - SF+ 
expressing TAP tagged APP stained with donkey anti mouse CY3 at 10x mag., Panel C - 
SF+ expressing TAP tagged APP stained with donkey anti mouse CY3 at 40x mag, Panel D 
- SF+ expressing myc tagged APP stained with 9E10 and donkey anti mouse CY3 at 100x 
mag, Panel E - SF+ expressing TAP tagged GFP stained with donkey anti mouse CY3 at 
40x mag, CY3 channel, Panel F - SF+ expressing TAP tagged GFP stained with donkey 
anti mouse CY3 at 100x mag, CY3 channel. 
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  E   F 
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4.1.2. Solubilization and purification of APP and 
BACE 
A number of mild, non-denaturing detergents was tested for efficiency of 
solubilization (Figure 4). These detergents can be ranked in decreasing order of 
efficiency for APP: 
DDM > DM ~ OG ~ Triton X-100~ NP40 ~ C12E8 > Bj35 ~ TW20 ~CHAPS,  
and for BACE: 
DDM ~ Triton X-100 ~ NP40 ~ C12E8 > Bj35 ~ TW20 ~ DM > OG > CHAPS. 
APP BACE
OG -  octylglucoside, DM - decylmaltoside, DOM -  
dodecylmaltoside, TX -  Triton X 100, TW -  Tween 
20, Bj 35 -  Brij 35
s -  supernatant, p -  pellet
numbers denote loaded amounts in microL
97
97
97
97
97
97
64
64
64
 
Figure 4 Western blot analysis of the soluble and insoluble fractions of SF+ cells expressing 
TAP tagged APP and BACE obtained with different detergents. HRP-conjugated rabbit 
anti goat antibody was used for detection. 
Our strategy was to purify the proteins by means of affinity chromatography, 
relying on specific proteolytical cleavage of the tag to facilitate highly specific 
elution of the tag-free protein. A series of similar constructs comprising a 
cleavable affinity tag was used to generate viruses and evaluate the efficiency 
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of cleavage. The constructs differed in the arrangement of the sequence 
modules: the C-terminal TAP or (myc)9 tag was linked to the protein sequence 
via a linker comprising one or two short, inert spacers (protease resistant, 
proline containing “kinker”) and either PreScission or TEV protease 
recognition site. The constructs and their generation is described in detail in 
Figure 5. 
Cut vector with HindIII and XhoI and insert tag
Stop
XhoI HindIII
TAG
MCS
Promoter
Cut with XhoI and PstI and
insert protease recognition
site or kinker
Cut with XhoI andNcoI and
insert target gene
Gene of interestATG
Gene of interestATG TAG Stop
PstI SalI
XhoI
TAG Stop
NcoI
PstI
XhoI
HindIII
TAG Stop
HindIIINcoI
XhoI
NcoI HindIII
PstI
Cut with XhoI and PstI and insert protease
recognition site or kinker; repeat this step as
many times as needed
PstI SalI
XhoI
TAG Stop
XhoI
NcoI HindIII
PstI
Gene of interestATG
Finally open with NcoI and XhoI and insert target gene
TAG Stop
XhoI
HindIIINcoI
ATG Gene of interest
     
Gene (APP, BACE or EGFP)
Hydrophillic linker, protease resistant (kinker)     SSGPSGSS
Protease site (PreScission, TEV, modified TEV)
myc9 tag, TAP tag (and TAP with 3 TEV sites), EE tag
 
 
Module Modular composition Sequence 
TAP tag CBD-TEV-ProtA* ** 
Myc9*** (-myc-)9 EQKLISEEDLN 
GluGlu (EE tag)**** - EEEEYMPME 
TEV site - ENLYFQ | G 
Modified TEV site - ENTYTQ | G 
PreScission site - LEVLF Q | GP 
Protease-resistant linker “kinker” - SSGPSGSS 
*     two IgG binding domains from B-domain of staphylococcal protein A 
**   Puig, O., Caspary, F., Rigaut, G., Rutz, B., Bouveret, E., Bragado-Nilsson, E., 
     Wilm, M., and Séraphin, B.: Methods 24, 218 (2001) 
***   highly immunogenic epitope of human c-myc oncogene 
**** Glu-Glu tag (EE tag) is a highly immunogenic peptide of the sequence 
      EEEEYMPME. 6aa long epitope EYMPME is sufficient for use as a tag 
      [Litts, J.: www.baculovirus.com]. Fusion proteins captured to anti-GluGlu resin 
      have been reported to be easily eluted with a  competing peptide EYMPTD 
  
Figure 5
 
Generation and resulting modular composition of the constructs.  
We have developed modular system for easy construction of C-tagged targets. The modules 
used were TAP tag (the TAP tag consists of a calmodulin binding domain linked to the C-
terminal protein A domains via a TEV site), modified TAP tag (3 chained TEV sites for 
more efficient cleavage), myc9 tag, EE tag, PreScission site, TEV site and a modified, less 
hydrophobic TEV site (ENTYTQ – G), and a protease-resistant linker (‘‘kinker’’) 
(SSGPSGSS). Targets (APP,BACE, EGFP) were amplified by PCR reaction and inserted to 
the generated vectors with varying constellation of the modules. 
In summary, all constructs performed reasonably well in facilitating protein 
pick-up and tag removal, however, it appears that it is useful to include a 
spacer at least upstream of the protease recognition site to preclude any 
potential sterical occlusion of the site, which would restrict the access of the 
protease to the site and thus would lead to inefficient cleavage. The results are 
reviewed in Figure 6. These results may be generally valid for any target 
protein. 
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Figure 6 Tag release efficiency in TAP-tagged constructs.  
LP PS: linker-PS-TAP, cleaved with PreScission, LPTEV: linker-PS-TAP, cleaved with TEV 
(ie within the TAP tag), LP3 PS: linker-PS-TAP with 3 TEV sites, cleaved with PreScission, 
LP3 TEV: linker-PS-TAP with 3 TEV sites, cleaved with TEV, PL: PS-linker-TAP, cleaved 
with PreScission, LPL: linker-PS-linker-TAP, cleaved with PreScission. 
For large-scale purification of APP and BACE, constructs pFB-APP-linker-PS-
TAP and pFB-BACE-linker-PS-TAP were used. Single step purification from 
1L of 48 h p.i. culture using the IgG Sepharose followed by a simple polishing 
step on the glutathion resin to remove the GST-tagged PreScission protease 
yields more than 2mg of homogenous (as judged by silver stained SDS-PAGE) 
preparation of tagless APP or BACE, eluted at a concentration of 0.1 – 0.8 
mg/mL or 0.1 – 0.5 mg/mL respectively Figure 7. 
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Figure 7 SDS-PAGE analysis of the purified BACE preparation. 
A - Coomassie Brilliant Blue R-250 stained gel: First lane – prestained molecular weight 
marker, second lane – BACE (~2µg); the lower molecular weight band is the GST-tagged 
PreScission protease used for elution. It is later removed with the help of glutathion 
sepharose. B – SimplyBlue stained BACE after PreScission removal, C – SimplyBlue stained 
APP preparation, D - silver stained gels: first lane – molecular weight marker, second lane – 
BACE (~200ng), third lane APP (~300ng). All gels were 4-12% NuPAGE gel run in MOPS 
buffer 
4.2. Activity of the purified proteins 
BACE was capable of processing both a peptide substrate mimicking the 
cleavage site (Figure 8) of the APP protein and the APP protein itself (see 
further). The purified APP was cleaved by BACE at the correct site (see 
further). 
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Figure 8 Reaction progress curves recorded for cleavage of the amyloido-mimetic peptide 
substrate FS-1 by BACE. Curves resulting from using different amounts of BACE 
(indicated) are shown. Concentration of the substrate was constant. 
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4.2.1. Optimal cleavage conditions in vitro 
In vitro, optimal pH for cleavage had already been reported for the soluble 
BACE ectodomain to be 4.5 [1]. Concerning the pH, we have obtained very 
similar results with the purified full-length BACE (pH optimum ~ 5, data not 
shown). However, unlike the soluble ectodomain, the full-length 
transmembrane protein requires a detergent for solubility – and activity. The 
identity and concentration of detergent is critical. Anionic detergents (cholate, 
deoxycholate, SDS) were found to be strongly deactivating already below the 
cmc, and while sugar-based detergents (dodecylmaltoside, octylglucoside) were 
able to support BACE activity at a particular concentration (OG below or at 
around 0.5xcmc, dodecylmaltoside up to 1xcmc), OG became strongly 
deactivating at higher concentrations (no activity of BACE observed at 2xcmc 
OG). In our assays with solubilized BACE, we have routinely used 0.025% w/v 
Triton X-100♣.  
Since the full-length APP695
♠ does not exhibit any easily measurable activity, 
its “activity” was only assessed in terms of being able to serve as a substrate 
for BACE. We have found that the purified APP was cleaved by BACE at the 
correct site (as judged by sequence-specific antibody reactivity; the cleavage 
site is EVKM|DA at the 596|597 position) in Triton X-100, as well as in 
proteoliposomes (Figure 9). Purified APP degrades slowly, and at a lower pH 
the degradation proceeds faster, which results in non-specific depletion of the 
β-secretase substrate, and thus the BACE activity is deceptively weaker - the 
production of the β-cleaved ectodomain is lower. Therefore all the assays 
involving the full-length APP were performed at pH 6.6 – 6.8.  
                                                
♣ however, this turned out not to be the best choice, as Triton from different suppliers, as 
well as different batches of the Triton from the same supplier behaved very differently in 
terms of supporting BACE activity; an effort was made to use the very same aliquot of the 
detergent for all experiments, however, this was not always possible. In addition, it appears 
that the quality  of  Triton deteriorates over time. 
♠ the longer isoforms containing the KPI domain can be assayed for their inhibitory effect on 
serine proteinases 
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Figure 9 Detection of the β-cleaved ectodomain of APP by SDS-PAGE and Western 
blotting. 
The cleavage was performed at different conditions (pH 5 or 7, presence of inhibitors, 
cleavage in TX100 or in brain lipid proteoliposomes) and equivalent amounts were loaded. β-
cleaved ectodomain was detected with an antibody (ANGU) specific for the newly generated 
N-terminus of the cleaved ectodomain. The lanes are assigned to the particular conditions 
below. 
Lane 1...brain proteoliposomes, pH 5 
Lane 2...brain proteoliposomes, pH 7 
Lane 3...brain proteoliposomes, pH 5, in presence of protease inhibitor cocktail 
Lane 4...brain proteoliposomes, pH 5, in presence of BACE inhibitor (Inhibitor III, 
Calbiochem) 
Lane 5...Triton X-100, pH 5 
Lane 6...Triton X-100, pH 7 
Lane 7...50ng full-length APP 
4.3. Protein reconstitution in LUVs to form 
proteoliposomes 
The successful method for reconstituting both APP and BACE, separately or 
together, was reconstituting the proteins into preformed LUVs that had been 
pre-saturated with detergent. The detergent that gave best results for BACE 
was HEGA10, while the highest recoveries of liposomes-associated APP were 
obtained with octylglucoside. Protein insertion was followed by gel filtration by 
which means virtually all detergent was removed. 
4.3.1. Recovery and specific activity of BACE 
reconstituted in total brain lipid vesicles 
The detergent-mediated reconstitution procedure presented here relies on 
incorporation of protein into preformed liposomes [70] and yields BACE 
reconstituted directionally (>80% ectodomain outside, Figure 10) in large 
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unilamellar vesicles; the yield was typically 15 – 30% of protein input by 
weight. The sidedness of the insertion did not depend on the lipid composition 
of the vesicles. Stable membrane-spanning insertion of BACE was confirmed by 
treatment with 0.1M Na2CO3, pH 11.3 followed by flotation in a density 
gradient. Virtually all BACE (as judged by silver stained SDS-PAGE) 
remained associated with the lipids (floating fraction – Figure 11). In addition, 
we performed immunoelectronmicroscopy of the total brain lipid 
proteoliposomes. We observed vesicles ~ 50 – 200 nm in diameter, heavily 
labelled with anti-BACE antibody (Figure 12). Virtually all immunodetected 
BACE was found to be membrane associated. 
98
62
49
38
PC:PE PC:PE:PS PC:PE:cbro:chol
protK
 Tx+Tw
+ + + + + +
+ + +-
-
-
-
- - -
-
-
64
97
191
protK
TX+Tw
-
- -+
+ +
total brain
 
Figure 10 Analysis of the topology of reconstituted BACE by western-blotting.  
Proteoliposomes of different lipid compositions were treated with proteinase K either in 
presence of detergent (TX+Tw) or without detergent, as indicated below the blot. For 
details, see the Materials and methods section. 
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Figure 11 SDS-PAGE analysis of proteoliposomes treated with 0.1M sodium carbonate after 
flotation in a density gradient. 
Lane 1 – molecular weight marker, lanes 2 – 8 fractions from top (floating fraction associated 
with lipids) to bottom (load). 
The specific activity of BACE reconstituted in total brain lipid vesicles was at 
least 3-fold higher than that of the purified BACE in 0.02% Triton X-100, as 
judged by cleavage of the soluble fluorogenic substrate which mimics the 
cleavage site of the Swedish APP mutant. 
Proteoliposomes consisting of BACE and total brain lipids were characterized 
by high reconstitution efficiency, reproducible activity, and stability (activity 
remains unchanged for several months when stored at 4°C). BACE 
reconstituted in total brain lipid liposomes was therefore chosen as a standard, 
and reconstitution in total brain lipid liposomes was always performed as a 
control together with other samples. In this section, the specific activity of 
BACE will be expressed as a percentage of the specific activity determined for 
brain lipid proteoliposomes. 
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Figure 12 Immunoelectronmicroscopy of the proteo-LUVs probed with anti-BACE antibody 
recognizing its ectodomain followed by 6nm-gold conjugated secondary antibody. 
4.4. BACE activity in proteoliposomes of 
different lipid compositions 
4.4.1. Activity in complex lipid mixtures 
There are hundreds of lipid species present in cells, and the reasons for such 
diversity are poorly understood. One way to study this complexity is to 
analyze how lipids regulate activities of membrane proteins in a reconstituted 
system. We therefore dissected the total brain lipid extract, and attempted to 
elucidate which lipid species are responsible for supporting BACE activity. 
As a control, a mixture mimicking the total brain lipid extract was mixed from 
individual components based on the known glycerophospholipid composition 
(data from Avanti catalog) and estimated amounts (TLC) of SM, 
glycosphingolipids and cholesterol. The composition was as follows: 
PC:PE:SM:cerebrosides:chol:gangliosides:PS:PA:PI (10:17:27:10:15:5:11:3:2 
w/w). 
BACE activity in this mixture was determined to be 95±12% of TBLE (total 
brain lipid extract). 
Since interpretation of the effects caused by a particular lipid species in 
complex lipid mixtures such as total brain lipids is problematic, we proceeded 
to investigate BACE activity in various simpler lipid mixtures of defined 
headgroup compositions, ranging from simple pseudo-binary mixtures to more 
complicated mixtures of up to 6 components. 
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4.4.2. Specific activity of BACE reconstituted in 
glycerophospholipid and 
glycerophospholipid:cholesterol vesicles 
Glycerophospholipids are the most abundant phospholipids in living cells, of 
which phosphatidylcholine accounts typically for up to 50% in mammalian 
cells. Specific activity of BACE in pure PC (brain PC or synthetic POPC) 
vesicles was not determined due to extremely low recoveries (<5%). It was 
clear, however, that specific activity in PC vesicles was several-fold (at least 3-
5 -fold) lower than that of BACE in TBLE vesicles. 
Recoveries improved somewhat when cholesterol was included, therefore 
POPC:cholesterol 2:1 (mol/mol) was used instead. Specific activity of BACE in 
POPC:cholesterol vesicles is ~5-fold lower than in TBLE vesicles (Figure 13). 
It has been shown that membrane proteins often require PE for activity, PE 
serving as a “chaperone” [75] and, along with other “nonbilayer lipids”, PE 
seems to be important for maintaining the physical state of the bilayer, 
allowing the membrane to readily undergo local rearrangements in response to 
changes in external conditions [76]. However, in the case of BACE, including 
20% of PE did not lead to any significant increase in BACE activity (26±12 % 
relative to TBLE, Figure 13).  
On the other hand, there was a strong effect of negatively charged 
phospholipids on BACE activity. PC:PS (80:20 w/w) supported BACE activity 
to 58±4 % of TBLE, while mixtures of PC:PE:PS and PC:PE:PA (60:20:20 
w/w) brought the specific activity of BACE virtually to the level of TBLE, 
resulting in 99±9 %, and 135±31 % of TBLE activity, respectively (Figure 13). 
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Figure 13 Specific activity of BACE reconstituted in vesicles composed of 
glycerophospholipids. PC, PE, and PS were of brain origin except for cholesterol (sheep 
wool) and PA (produced from egg PC). experiments Where applicable, PE, PS, and PA are 
each present at 20% w/w. The last bar corresponds to a mixture of POPC:chol 2:1 mol/mol. 
BACE was reconstituted in LUVs of given compositions by detergent mediated 
reconstitution followed by flotation in a density gradient to separate resulting 
proteoliposomes from unreconstituted protein. BACE content was determined in each 
sample, and specific activity of BACE in each particular mixture measured and is expressed 
in % relative to the specific activity of BACE in total brain lipid protoeliposomes. 
4.4.3. Specific activity of BACE reconstituted in 
vesicles composed of glycerophospholipids, 
(glyco)sphingolipids, and cholesterol 
Sphingolipids and cholesterol are essential components of lipid rafts, and 
various pseudo-ternary mixtures of PC, SM, and cholesterol mixed at ratios 
that allow for ld-lo phase coexistence, have been shown to be useful to imitate 
lipid rafts. Specific activity of BACE in the lo phase forming mixture of 
PC:SM:chol (1:1:1 or 2:2:1 mol/mol) did not dramatically differ from 
POPC:chol, resulting in 29±16 % of TBLE activity. 
In order to assess the role of cholesterol in modulating membrane properties 
relevant to BACE activity, we used proteoliposomes consisting of 
PC:PE:SM:gangliosides supplied with increasing amounts of cholesterol (0, 7.5, 
and 15% w/w) substituting for SM (25, 17.5, and 10% w/w final) to yield 
cholesterol:sphingolipid molar ratios of 0, 0.4, 2.5. There was an increase in 
BACE activity along with increasing cholesterol:sphingolipid molar ratios as 
follows: 18±1% for PC:PE:SM:gangliosides 50:20:25:5 w/w, 28±1% for 
PC:PE:SM:gangliosides:chol 50:20:17.5:5:7.5 w/w, and 36±1 % TBLE for 
PC:PE:SM:gangliosides:chol 50:20:10:5:15 w/w (Figure 14A) This last mixture 
is listed in Table 1 and is marked ˝0˝. 
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When sphingolipids in this mixture (SM and gangliosides) were replaced with 
cerebrosides (PC:PE:cerebrosides:chol 50:20:15:15 w/w – mixture 1 in Table 1), 
specific activity was determined to be 46±4%. Even though this increase is 
relatively small, the trend seems to be confirmed in another mixture containing 
both cerebrosides (12%) and a small amount of SM (5%), which is present at 
the expense of lowering PC content accordingly (PC:PE:SM:cerebrosides:chol 
45:20:5:15:15 w/w – mixture 3), in which BACE displays specific activity of 
58±6 %, representing ~20% increase (Figure 14B). In addition, we found that 
cerebrosides, as well as synthetic C8-glucosylceramide, greatly enhance the 
activity of purified soluble ectodomain of BACE in presence of Triton X-100: 
~20nM BACE in presence 0.1mM cerebrosides or C8-glucosylceramide displays 
almost 9-fold or 4-fold higher activity than a control in Triton X-100 only. 
Such increase was only observed with cerebrosides and glucosylceramide, and 
not with any other lipids in solubilized state. However, only a mild effect was 
observed with the full-length BACE (~1.2 fold increase with 0.1mM 
glucosylceramide over the control). This may be due to the interference of 
Triton X-100, since higher concentrations are necessary for full-length BACE. 
The effect of cerebrosides was futher investigated in mixtures including anionic 
phospholipids. 
PC PE SM cbro chol PS PA activity ± SEM
1 44 18 0 12 26 0 0 46 4
2 35 18 14 0 26 8 0 51 3
3 40 18 5 12 26 0 0 58 6
4 26 18 23 0 26 8 0 61 5
5 35 18 0 12 26 8 0 62 2
6 31 18 5 12 26 8 0 67 5
7 35 18 5 12 26 0 5 78 4
8 22 18 5 12 26 17 0 97 7
9 46 18 5 0 26 0 5 98 12
10 34 18 5 0 26 17 0 64 10
"0" 44 18 9 0 26 36 12% ganglios.  
Table 1 Results and compositions for lipid mixtures consisting of glycerophospholipids, 
sphingolipids, and cholesterol. Composition is given in mol%. All lipids were of brain origin 
except for cholesterol (sheep wool) and PA (produced from egg PC). BACE was 
reconstituted in LUVs of given compositions by detergent mediated reconstitution followed 
by flotation in a density gradient to separate resulting proteoliposomes from unreconstituted 
protein. BACE content was determined in each sample, and specific activity of BACE in 
each particular mixture measured. Activity represents specific activity of BACE in % relative 
to BACE reconstituted in total brain lipid proteoliposomes. The value represents the average 
of results obtained from 2-7 independent reconstitution experiments. 
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Figure 14 Influence of cholesterol and cerebrosides on BACE activity. All lipids were of brain 
origin except for cholesterol (sheep wool). BACE was reconstituted in LUVs of given 
compositions by detergent mediated reconstitution followed by flotation in a density gradient 
to separate resulting proteoliposomes from unreconstituted protein. BACE content was 
determined in each sample, and specific activity of BACE in each particular mixture 
measured and is expressed in % relative to the specific activity of BACE in total brain lipid 
protoeliposomes. A, increasing cholesterol:sphingolipid ratio correlates with incresing specific 
activity of BACE. All three mixtures contained 50% w/w PC, 20%w/w PE and 5% w/w 
gangliosides. Increasing amounts of cholesterol (indicated in % w/w) were introduced at the 
expense of the SM content. B, cerebrosides seem to enhance BACE activity. The three 
mixtures contained 45-50% w/w PC, 20% w/w PE, and 15% w/w cholesterol; in addition, 
the mixture lacking cerebrosides (light gray bar) contained 5% w/w gangliosides and 10% 
w/w SM, while the mixtures represented by the dark grey bars contained 10% w/w 
cerebrosides and the right-most mixture contained additional 5% w/w SM. 
4.4.4. Specific activity of BACE reconstituted in 
vesicles composed of glycerophospholipids, 
(glyco)sphingolipids, cholesterol, including 
negatively charged glycerophospholipids 
Mixtures listed in Table 1 will be throughout this paragraph referred to by 
their numbers enclosed in braces {}. 
In pure glycerophospholipid vesicles, anionic phospholipids (PS and PA) 
promoted BACE activity notably. In vesicles composed of 
glycerophospholipids, sphingolipids, and cholesterol, the outcome was 
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dependent on the sphingolipid content of the mixture: In otherwise identical 
mixtures (either with {3,6,8}, or without {˝0˝,2,10}, cerebrosides), there was a 
clear trend of increasing BACE activity with increasing amounts of PS (Figure 
15). However, in mixtures with different sphingolipid content, the response to 
the addition of PS varied (compare {2,4,5,6}). Thus the ratio of sphingolipid to 
phospholipid (or perhaps cholesterol) content may play a role as well. We 
further asked if cerebrosides contribute to supporting activity in mixtures of 
PC:PE:±SM:chol:PS. Comparing {0,2,4,10} to {3,5,6,8} revealed higher activities 
in the mixtures that included cerebrosides. 
With PA, the situation is somewhat different. Introducing 5% PA to mixture 
of PC:PE:SM:cbro:chol promoted activity more notably than 8% PS (compare 
{7,3,6}). However, when in this case cerebrosides are omitted, the resulting 
mixture {9} displays high activity. 
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Figure 15
 
Specific activity of BACE in vesicles composed of PC, PE, cholesterol, SM, 
±cerebrosides, ±PS/ ±PA. Anionic phospholipids and cerebrosides affect BACE activity: 
Activity increases with increasing PS content in proteoliposomes of otherwise identical 
compositions, and cerebrosides included at the expense of PC in proteoliposomes of otherwise 
identical compositions further stimulate the activity.
 
BACE was reconstituted in LUVs by detergent mediated reconstitution followed by flotation 
in a density gradient to separate resulting proteoliposomes from unreconstituted protein. 
BACE content was determined in each sample, and specific activity of BACE in each 
particular mixture was measured and is expressed in % relative to the specific activity of 
BACE in total brain lipid protoeliposomes ( =100%).  
In all mixtures, PE is present at a concentration of 18% mol/mol (20% w/w), cholesterol at 
26% mol/mol (15% w/w), and SM at 5% mol/mol except for sample “0” (9% SM) and “2” 
(14 mol % SM). Where applicable, cerebrosides are present at a concentration of 12 mol%. 
Amounts of PS/PA are indicated. The numbers on the bars indicate the mixture number in 
Table 1.   
“0”    “3”              “2”    “6”             “10”  “8”               “9”    “7” 
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4.4.5. Activity in cholesterol-depleted 
proteoliposomes 
Methyl-β-CD is often used for cholesterol depletion from cell membranes. Using 
this same approach on proteoliposomes allows to distinguish between the 
requirement for cholesterol to maintain the activity of reconstituted BACE as 
opposed to the requirement for cholesterol presence during membrane insertion 
of BACE. When cholesterol was depleted either from the reconstituted 
proteoliposomes, or from liposomes before BACE insertion by means of methyl-
β-cyclodextrin treatment (~5mM), activity of BACE was dramatically reduced 
(~4-fold) in comparison with untreated control, while there was no effect on 
non-reconstituted solubilized BACE (Figure 16). This experiment was 
performed with brain lipids proteoliposomes and soybean lipids 
proteoliposomes. The total soybean lipids do not contain cholesterol, but 
contain significant amount of plant sterols that play a role analogous to 
cholesterol in maintaining membrane properties. 
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Figure 16 Specific activity of BACE in proteoliposomes after treatment with mβCD. 
Proteoliposomes with reconstituted BACE and control (BACE in Triton X-100) were treated 
with 5mM mβCD for 15min. Activity was then measured after dilution with the assay buffer. 
Activity in non-treated controls was set to 100%. 
4.5. Reconstitution of APP and BACE into 
giant unilamellar vesicles 
Fluorescently labeled proteins were used for reconstitution into giant 
unilamellar vesicles (GUVs). BACE and APP were labeled using the amino-
reactive dyes Cy5 (excitation maximum 649nm, emission maximum 670nm) 
Results  49 
Lucie Kalvodova  Lipid requirements for β-secretase activity of BACE 
and Alexa 488 (excitation maximum 495nm, emission maximum 519nm) with 
200 – 300% efficiency (ie 2-3 fluorophor molecules per protein molecule). The 
labeling had no influence on activity (data not shown). 
Upon reconstitution in LUVs, these large proteoliposomes were fused to form 
giant, mostly unilamellar proteoliposomes of 5 – 250 µm diameter. The proteo-
GUVs were stable for several hours. 
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4.5.1. Partitioning properties of BACE in giant 
unilamellar vesicles 
BACE has been previously found to be 
partially DRM-associated [77], however 
DRM association does not directly 
imply raft association. We therefore 
chose to approach the issue of putative 
raft association of BACE by probing 
the partitioning of BACE between the 
lo and ld phases in GUVs.  
As expected, distribution of BACE in 
pure DOPC vesicles (ld phase only) is 
homogenous (Figure 17A). However, 
we found that in a system with 
coexisting ld-lo phases BACE does 
indeed partition into the lo phase. In 
GUVs composed of 
DOPC:brainSM:cholesterol 2:2:1 
mol/mol (this mixture gives rise to 
large, microscopic domains of several 
µm in diameter), about 15-20% of 
BACE partitions into the lo phase - as 
judged from the fluorescence 
correlation spectroscopy measurements 
and confocal imaging (Figure 17B). 
When 1 mol % of GM1 (or more) is 
included in the membrane, then upon 
cross-linking with cholera toxin 
subunit B, redistribution of BACE 
occurred, BACE being almost equally 
distributed between ld and lo phases 
(Figure 17E,F). This may reflect a 
specific interaction of BACE with 
GM1. Presence of GM1 or brain 
gangliosides at ~2% mol/mol did not lead to any observable change in the 
specific activity of BACE in large proteoliposomes, however since we are aware 
of the putative role of GM1 in amyloidogenesis [for example 78,79], the 
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Figure 17 Confocal images of the proteo-
GUVs. Red channel – CY5-BACE, green 
channel in C – ld marker DiO, green channel 
in F and H – Alexa488-CTB. A – CY5-
BACE in DOPC GUVs; B – overview of 
CY5-BACE in DOPC:SM:chol (2:2:1 
mol/mol); C and D: CY5-BACE in 
DOPC:SM:chol:DiO (2:2:1 mol/mol + 0.1 
mol% DiO) – C: DiO, D: CY5-BACE; E and 
F: CY5-BACE in DOPC:SM:chol:GM1 
(2:2:1 mol/mol+ 0.1 mol% GM1) after cross-
linking with CTB; E: CY5-BACE, F: 
Alexa488-CTB; G and H: CY5-BACE in 
DOPC:SM:chol:GM1 (2:2:1 mol/mol+ 1 
mol% GM1) after cross-linking with CTB –
G: CY5-BACE, H: Alexa488-CTB. The 
scalebar in panels A, B, E, F, G, H is 20µm, 
in panels C, D 10µm. 
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possibility of engagement of GM1 or other gangliosides directly in regulating β-
cleavage itself will be further addressed in future experiments focusing on the 
interaction of BACE with full-length APP rather than with the peptide 
substrate. 
Diffusion coefficients of BACE measured by FCS were 3.5 x 10-8 ± 0.5 cm2s-1 in 
the ld phase of 2:2:1 DOPC:brainSM:chol, and 0.7 x 10-8 ± 0.1 cm2s-1 in the lo 
phase of the same system. 
4.5.2. Partitioning of APP in GUVs 
As expected, in a system with co-existing ld and lo phases (the same system 
was used as in the experiments involving BACE), the vast majority of APP 
partitions into the ld phase. While about 20% of BACE partitions into the lo 
phase, only less than 5% of APP was estimated to be lo-phase associated 
(Figure 18). 
APP behaved differently from BACE also in that cross-linking of GM1 (when 
included in the same system at either 0.1 or 1 mol %) did not influence the 
partitioning. 
 
Figure 18 Partitioning of Cy5-APP in GUVs. More than 95% of APP partitions into the ld 
phase of the system DOPC:SM:chol:DiO (2:2:1 mol/mol + 0.1 mol% DiO). From left to 
right, top to bottom: red channel, Cy5-APP; green channel, DiO; merge. 
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4.6. Co-reconstitution of APP and BACE in 
large proteoliposomes 
Finally, APP was co-reconstituted with BACE in large proteoliposomes (Figure 
19). The main obstacle was preventing cleavage of APP by BACE during the 
procedure.  
A B
C
 
Figure 19 Immunoelectronmicroscopy of the proteoliposomes comprising both APP and 
BACE. 
Detection: APP - 6E10 antibody + 12nm gold conjugated secondary antibody, BACE - 7523 
antibody + 6nm gold conjugated secondary. Panel A shows the raw image; the membrane 
outlines are weakly visible; the large dots correspond to APP, the smaller dots (difficult to 
see, see panel B) to BACE. Panel B shows a processed image (threshold applied) to make 
the gold particles stand out over the grainy background. The  red arrows indicate the 
position of the 6nm gold particles, the blue dashed lines copy the contours of the membranes. 
Panel C shows a digitally processed, enhanced image. 
Even though BACE shows very little activity towards the soluble fluorescent 
peptide at pH higher than 5.5 in solubilized state, the situation is dramatically 
different in proteoliposomes with full-length APP. Liposomal membranes 
provide only 2D space for APP and BACE, and thus the probability of BACE 
“finding and grabbing” APP is very high. In addition, the full-length APP may 
be a “better substrate” than the artificial peptide. Therefore the procedure used 
for reconstituting APP or BACE individually had to be modified somewhat for 
co-reconstituting APP with BACE together. First, the experiments were 
scaled-down so that smaller volumes were being processed – this shortens the 
time required for certain steps (gel filtration, centrifugation steps), thus also 
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limiting the cleavage. Second, the buffers were changed so that directly after 
the gel filtration step, the proteoliposomes were diluted into a buffer of pH 8 – 
8.2. In addition, all centrifugations were performed at 2oC. In spite of all these 
precautions, it was not possible to prevent the cleavage completely. 
4.7. Reconstitution of the β-secretase 
activity of BACE in proteoliposomes: 
cleavage of APP by BACE in 
proteoliposomes 
APP and BACE were co-reconstituted in proteoliposomes. The objective was 
to reconstitute the initial step of the amyloidogenic processing of APP (the β-
cleavage) in an environment mimicking the native environment – the lipid 
bilayer. The β-cleavage of APP was detected in proteoliposomes with APP and 
BACE reconstituted together at various ratios, but not when BACE was 
omitted (there is no detectable spontaneous β-ectodomain generation) Figure 
20. 
Next, it was important to investigate whether solubilized full-length BACE or 
the soluble BACE ectodomain are capable of β-processing of the membrane-
embedded APP, which does not seem to be the case (data not shown). 
 
Figure 20 Full-length APP co-reconstituted with BACE in total brain lipid proteoliposomes 
is cleaved at the β-cleavage site. Purified full-length APP was co-reconstituted with BACE 
in total brain lipid proteoliposomes and incubated at pH 7 at room temperature. 
Proteoliposomes were then loaded on SDS-PAGE gels (lane 1) along with control liposomes 
containing APP only (lane 2). Panel A shows a silver stained gel, panel B shows a western 
blot of a similar gel probed with anti-BACE antibody and an antibody specifically 
recognizing the β-cleaved ectodomain of APP. 
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While for BACE activity assays with the amyloidomimetic peptide substrate 
the optimal pH was ~4.8, it appears that the full-length APP is unstable in an 
acidic environment and it degrades rather fast at pH 5, as mentioned in 
paragraph 4.2.1. Thus in the artificial purified system, at low pH conditions, 
the β-secretase substrate is being non-specifically depleted. For this reason, all 
activity assays with the proteoliposomes comprising the full-length APP were 
performed at pH 6.6 – 6.8. 
4.7.1. β-processing of the full-length APP in 
proteoliposomes of different lipid compositions 
To follow the β-cleavage, an assay for detection of the β-cleaved ectodomain of 
APP was developed. The assay takes advantage of the MSD technology, 
(described in 3.2.11). Several capture/detection antibody combinations were 
tested before arriving at the current setup. Since it is impossible to completely 
quench BACE activity without denaturing the samples, the key requirement 
for both capture and detection antibodies was that they need to recognize 
denatured APP. The present procedure for preparing the sample for analysis 
thus includes solubilization of the proteoliposomes with high pH buffer (final 
pH 7.8) containing SDS/NP 40 detergent combination (SDS also deactivates 
BACE). In addition, the solubilized samples are shortly heated to 95oC. This 
treatment ensures good pick-up of both the full-length APP and the cleaved 
ectodomain by the capture antibody; only the β-cleaved antibody is however 
detected owing to the specificity of the detection antibody. Initially, a setup in 
which only the β-cleaved ectodomain was captured had been tested, but was 
later dismissed because of the problems caused by direct binding of the full-
length APP to the surface of the wells. With the current assay, approximately 
1ng/mL of the denatured β-cleaved ectodomain can be detected in 25µl total 
volume (which corresponds to 25pg total ectodomain).  
To quantitatively analyze the kinetics of the β-processing of APP in 
proteoliposomes is, however, a difficult task. While it is relatively 
straightforward and painless to analyze enzyme kinetics with soluble enzyme 
and substrate, when one is able to independently change the concentrations of 
both enzyme and substrate, studying kinetics of cleavage in proteoliposomes is 
substantially different. First,  with proteoliposomal sample, one does not have 
a full control over the amount of enzyme and substrate in the reaction mix: 
choosing a working concentration of the substrate automatically predetermines 
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the concentration of the enzyme and vice versa (varying the APP:BACE ratios 
during reconstitution of course does affect the ratio in the resulting 
proteoliposomes, however, the result is not predictable with 100% accuracy). 
Furthermore, due to the fact that APP and BACE are being co-reconstituted, 
the zero timepoint  of the reaction is not a bona fide zero point, because a 
certain fraction of the substrate had already been converted during the 
reconstitution procedure. Therefore, in order to compare enzyme activities in 
different samples, a number of requirements concerning the proteoliposomes 
samples have to be fulfilled. First, a need for favorable APP : BACE ratio. 
Ideally, the enzyme should be saturated with the substrate, i.e. the substrate 
should be present in great excess over the enzyme. Since this does not seem to 
be possible to achieve with the current method, samples with similar ratios  
and total amounts of APP and BACE were used. Second, the conversion at 
timepoint zero (set as a moment of addition of the reaction buffer) should be 
similar, and negligible relative to the total amount of APP present. Third, the 
inter-vesicular distribution of APP and BACE, as well as the total protein-to-
lipid ratio (which is a measure of the total protein surface density, and thus is 
analogous to 3D concentration) has to be comparable. Keeping all these 
restrictions in mind, it is a major problem to find samples fit for comparison. 
Great care was taken to use suitable samples of total brain lipid 
proteoliposomes and POPC proteoliposomes, and enzyme progress curves were 
recorded. Since it turns out that the quantification of the APP and BACE 
content by dot-blotting may be burdened with a considerable error, the current 
results should be regarded as semi-quantitative only. 
The results indicate that BACE co-reconstituted with APP in POPC 
proteoliposomes performs reproducibly poorer than in total brain lipid 
proteoliposomes. A representative pair of reaction progress curves is shown in 
Figure 21. In samples with approximately two-fold excess of APP over BACE, 
this and other experiments indicated the halftime of the β-cleavage in total 
brain lipids to be in the range of 0.5 - 4 minutes (2 minutes for the case shown 
here), while in POPC vesicles much longer times were needed, generally 
exceeding 5 minutes (17 minutes for the case shown here). 
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Figure 21 Reaction progress curve for APP cleavage by BACE in brain lipids and POPC 
proteoliposomes. The two samples had essentially identical content of APP and BACE (as 
judged by dot blot), with APP-to-BACE ratio of about 2. Reactions were done in 
citrate/phosphate buffer pH 6.6. Samples were removed at relevant timepoints, the reaction 
was stopped by adding SDS/NP40-containing buffer pH 8.8, and samples were heated shortly 
to 95oC. The β-cleaved ectodomain was then determined using the MSD assay. The fitted 
curves are displayed only to indicate the trend of the reaction progress; the actual fit does 
not analytically describe the real process (general saturation model with offset was used). See 
the footnote♥ and discussion for more information on fitting reaction progress curves. 
                                                
♥ Fitting reaction progress curves is not trivial. In the case of a standard enzyme reaction 
following the classical irreversible Michaelis-Menten scheme, integrating the fundamental 
equation dP/dt = (Vlim*S)/(Km+S) [where P denotes the momentary product 
concentration, S the momentary substrate concentration, and Vlim and Km are the maximal 
velocity and Michaelis constant, respectively] leads to an equation with implicitly expressed 
P: P-K*ln(1-P/S0)-Vlim*t=0 [S0 denotes the initial substrate concentration; then obviously 
P= S0-S]. It has been shown that no algebraic arrangement of this equation can convert the 
expression into an expression suitable for standard regression analysis. Specialized software 
for fitting curves to implicit functions is required. Another option is parameter optimisation 
using the integral version of the equation, ie P=INT(Vlim*S/(Km+S))dt. Like in the case of 
implicit functions, this approach requires specialized software tools. Even though not as 
convenient as standard curve fitting, either of the two approaches is feasible. However, in 
comparison to standard regression, these methods can only yield reasonable results provided 
that the dataset consists of sufficient number of experimental points with minimal error and 
precisely defined initial conditions (which is not the case of the presented data). Another 
problem in this particular case of cleavage of APP co-reconstituted with BACE in 
proteoliposomes is that this process may not obey the simple Michaelis-Menten model. See 
Discussion for more information.   
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5. Discussion 
Membrane proteins are designed to reside and function in lipid bilayers and 
hence the properties of the bilayer affect the biological activity of the 
associated proteins.  
Being an integral membrane protein, the aspartic protease BACE is likely to 
respond to its lipid environment on a molecular level (conformation, 
oligomerization, intramolecular charge distribution etc.) in a way that could 
eventually affect its activity. BACE activity is in cells directed towards 
another integral membrane protein, APP, which is a precursor of the 
neurotoxic amyloid peptide (Aβ). Previous work had indicated that production 
of the Aβ peptide may be linked to lipid metabolism and composition of cell 
membranes. In this thesis, the issue of involvement of membrane lipids in 
modulating β-secretase activity was addressed. 
In order to experimentally address this issue, BACE and APP were purified 
and reconstituted in proteoliposomes of defined lipid compositions, and the 
influence of the lipid composition on BACE activity was analyzed. 
First, we investigated the dependence of the proteolytic activity of BACE 
irrespectively of APP as the substrate, but using a soluble peptide substrate, 
on the composition of the lipid bilayer in a reconstituted system consisting of 
purified full-length BACE and defined lipids.  
Even though the soluble BACE ectodomain alone displays proteolytic activity, 
a higher specific activity of the full-length BACE has been reported [80]. It was  
proposed that the higher specific activity of the full-length protein may be due 
to dimerization, which would occur exclusively when the ectodomain is 
attached to the membrane. Using BN-PAGE, we have detected dimers of the 
purified recombinant ectodomain of BACE as well as oligomers of the full-
Activity of 
the soluble 
ectodomain 
of BACE is 
lower than 
that of the 
full-length 
protein  
 
Oligomriza-
tion of BACE 
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length BACE (data not shown). Dimerization thus does not seem to be strictly 
dependent on membrane attachment, which may nevertheless promote self-
association, and if that is the case then chances are that certain lipids support 
dimerization or stabilize dimers better than other. This issue was however not 
pursued any further since straightforward but adequate methods for analysis of 
oligomerization of membrane proteins are not readily available. While it is 
relatively painless to investigate oligomerization of a soluble protein (by gel 
filtration, velocity gradient centrifugation and other basic methods), with 
membrane proteins the situation is very different. In principle, all methods that 
can be used on soluble proteins can also be used on solubilized membrane 
proteins, however it is not clear whether the results concerning oligomerization 
of detergent-solubilized membrane protein are relevant to its native, 
mambrane-embeded state. Methods allowing evaluation of oligomerization of 
proteins directly in membranes are few, require expertise, and are generally 
experimentally demanding. These methods include FRET, cross-correlation 
analysis of the labeled proteins, chemical cross-linking and other [reviewed in 
81].  
Importantly, upon reconstitution of the full-length BACE in proteoliposomes, 
we observed further increase in specific activity (full-length solubilized BACE 
displayed a higher activity than the ectodomain alone, but full-length 
membrane-embedded BACE was more active than the full-length solubilized 
BACE). Thus, it appears that neither oligomerization nor the absence of 
potentially inactivating detergent can fully explain this increase in specific 
activity, because the increase was also found to depend on the lipid 
composition of the proteoliposomes. 
We had hypothesized that lipids differ in their capacities to support enzymatic 
activity of BACE. Our data 1/ back up the concept of a multiple-lipid system 
being generally more capable of supporting protein activity, 2/ suggest lipid 
candidates involved in affecting BACE activity. We focused on investigating 
effects of lipids defined by their headgroups, and did not examine impact of 
acyl chain composition. 
All cell membranes comprise anionic glycerophospholipids - PA, PIs, and PS, 
the latter two being confined almost exclusively to the cytoplasmic leaflet of 
the membrane. Negatively charged lipids have been identified as regulators of 
function of numerous integral membrane proteins (glucose transporter, Ca2+-
ATPase, (Na+, K+)-ATPase [82 and references therein], nicotinic 
acetylcholinesterase receptor [82 and references therein, 83]).  
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We have demonstrated a strong effect of PS and PA on BACE activity, which 
is further enhanced by PE. Considering the fact that anionic 
glycerophospholipids localize mainly to the cytoplasmic leaflet of the 
membrane, and that the catalytic domain of BACE is localized on the other 
side of the membrane, it is clear that especially in context of the experiments 
performed with artificial soluble peptide which may interact with the 
membrane surface, it is necessary to interpret these results carefully. We can 
envisage four possible, mutually not exclusive, ways, in which PS or PA could 
encourage proteolysis by BACE: electrostatic interactions at the membrane 
interface, a direct interaction of BACE with a negatively charged lipid in the 
outer leaflet, a direct interaction of the cytoplasmic tail in the inner leaflet of 
the proteoliposome, and anionic lipids influencing the bulk membrane 
properties other than electrostatic.  
Local electrostatic effects may result in changes in local ion concentrations 
(charged peptide substrate, H+ - local decrease in pH). Electrostatic 
interactions involving anionic glycerophospholipids (which account for ˜30% of 
cellular phospholipids) belong to the fundamental principles of biological 
interactions at membrane interfaces. Common characteristic of these non-
specific events is the requirement for a minimum interfacial concentration 
(˜10mol%) of the anionic phospholipid before an effect is observed [84]. Since 
we see a striking effect already at a relatively low concentration of PA (5%), it 
is not clear whether this is the case in our system, where externally exposed 
anionic phospholipids could be responsible for the recruitment of the peptide 
substrate to the membrane. In order to avoid complications of this type, it 
would be necessary to employ proteoliposomes with asymmetrically distributed 
lipids, restricting the anionic lipids to the inner side to mimic the topology of 
cell membranes. However, such systems have not yet been used for membrane 
protein studies, even though several promising attempts to produce 
asymmetrical liposomes have emerged [85, 86]. 
Under ionic strength conditions much lower than in our system (5 - 10mM), 
the local pH near the surface of the membrane containing anionic 
phospholipids is 1.5 - 2 pH units lower than in bulk solution [87]. Optimal pH 
for BACE activity is ˜4.5, the activity steeply dropping above pH 5.5. If the 
local pH effects caused by the presence of PS/PA were the major mechanism 
for stimulating BACE activity in proteoliposomes, one would expect the 
decline in activity of reconstituted BACE to be less steep with increasing pH, 
which was not the case (not shown). 
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Another way in which anionic lipids may be involved in stimulating BACE 
activity is a direct interaction of BACE with a negatively charged species in 
the outer leaflet, resulting in changes in BACE conformation, oligomeric state, 
or charge distribution. The only negatively charged species continuously and 
extensively present in the outer leaflet of the plasma membrane are charged 
glycosphingolipids (gangliosides and sulfatides). Role of gangliosides and 
sulfatides was not thoroughly investigated in this study. Small amounts of 
gangliosides (5% w/w, 2% mol/mol) used in mixtures with PC, PE, SM, and 
cholesterol, did not cause any observable change in activity. In addition, an 
interaction of the cytoplasmic tail with PS or PA (or PI which was not 
experimentally tested in this study) in the inner leaflet could as well affect the 
conformation of the protein. Anionic phospholipids have also been shown to 
strongly influence other bulk membrane properties, including lipid packing 
density and perturbing the bilayer structure [84]. This phenomenon can 
account for facilitated penetration of the transmembrane domain, resulting in 
increased stability of BACE insertion, eventually affecting its activity. 
As opposed to anionic phospholipids, glycosphingolipids mainly localize to the 
outer leaflet of the plasma membrane, and brain tissue in particular has been 
found to contain high amounts of neutral glycosphingolipids - cerebrosides. 
Brain cerebrosides contain mostly long saturated fatty acid chains (C22:0, 
C24:0, and also C24:1 (information from Avanti catalog)). The stimulatory 
effect of cerebrosides in proteoliposomes on BACE activity may be owing to 
these long acyl chains or may be due to the presence of carbohydrate 
headgroups that besides thickening the layer of perturbed water near the 
membrane interface may interact with the BACE ectodomain. Interestingly, 
cerebrosides also activate soluble BACE lacking the transmembrane and 
cytosolic part, which further supports the possibility of saccharide headgroup 
interacting with the BACE ectodomain. 
Both APP and BACE have been suggested to associate, to a certain extent, 
with lipid rafts, and thus rafts had been implicated in β-cleavage regulation. 
Since our hypothesis assumes β-cleavage of APP to happen primarily in lipid 
rafts, in order to examine the possibility of BACE requiring lo phase domain to 
assume a high-activity state, we used liposomes consisting of PC:SM:chol (2:2:1 
or 1:1:1 mol/mol, there was no significant difference when either POPC or 
DOPC was used), which has been shown to phase separate at relevant 
temperatures [88]. Even though in GUVs BACE does not show a preference for 
the lo phase, the measured 15-20% seems to be a significant fraction when 
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compared to other proteins that have been probed using the same technique. 
25-30% of the GPI-anchored placental alkaline phosphatase (PLAP), which has 
become a ˝prototype of a raft protein˝, and is recognized as a raft marker, 
partitions into lo phase in the same system [89], and also only 10 - 20% of a 
LAT-derived peptide was reported to partition in lo phase. On the other hand, 
syntaxins or bacteriorhodopsin partition almost exclusively (95-99%) into ld 
(N. Kahya, personal communication). Interestingly, partitioning of BACE into 
lo phase seems to be enhanced by cross-linking of the membrane components 
(we have used the pentavalent CTB to cross-link GM1), offering potential 
means of regulating BACE-raft association in cells (of course not via cross-
linking with CTB, but perhaps thanks to binding of other, endogenous lectin to 
membrane components, or directly to BACE). These experiments therefore 
further back up the hypothesized ability of BACE to (dynamically) associate 
with rafts (lo phase), possibly in a flexible, adjustable manner, which is a 
feature compatible with the role of BACE as a regulated protease. 
Interestingly, only negligible, barely detectable amounts of APP were found to 
partition in lo phase in the same system, and cross-linking of GM1 with CTB 
did not affect its ld-lo distribution. Does this mean that the β-cleavage does 
not happen in rafts after all? This question is difficult to answer considering 
current data. It is important to emphasize that the extent to which BACE 
associates with lo phase in GUVs is by no means usual for a transmembrane 
protein. Therefore it seems reasonable to consider this fact significant and 
potentially physiologically relevant. It is possible that our system is missing a 
component necessary for APP to find its way to the lo phase; our composition 
PC/SM/cholesterol (with only minor GM1 amounts) only very roughly mimics 
physiological conditions (complexity of lipid composition, leaflet asymmetry). 
APP may require a certain lipid (or protein) to change its partitioning 
preferences. Clearly, more experiments are needed to elucidate this issue; such 
experiments are still on the schedule, including cross-linking of APP with 
antibodies or a lectin, as well as improving lipid composition of the GUVs to 
better imitate physiological conditions while still providing coexisting ld/lo 
phases. 
Unfortunately, GUVs with both APP and BACE were of poor quality not 
suitable for detailed analysis by FCS; the preliminary results (from imaging) do 
not indicate any differences in partitioning from the systems with individually 
reconstituted proteins.  
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Even though neither cholesterol alone, nor the lo phase in the system per se 
can account for full activation, cholesterol levels clearly influence BACE 
activity. We show correlation between cholesterol levels and BACE activity in 
mixtures including PC, sphingolipids and PE. While a direct interaction of 
BACE with cholesterol (BACE was found to label strongly with 
photocholesterol in the native environment of the cellular membranes) cannot 
be excluded, it seems more probable that cholesterol content primarily affects 
the bulk properties of the liposomal membrane. In accord with this observation 
is the steep drop in activity of BACE in both asolectin (contain plant sterols) 
and total brain lipid proteoliposomes upon treatment with methyl-β-
cyclodextrin. 
It should be noted that our experimental approach provides information on the 
mean specific activity of BACE in proteoliposomes of a particular average lipid 
composition. We cannot distinguish between a situation where a part of the 
pool of the reconstituted BACE would be completely inactive, and the rest 
present in a highly activated state (which may be the case in bilayers 
displaying lateral domain separation), from a situation where all BACE 
molecules would display the same activity. Despite this limitation, we have 
identified 3 classes of lipids affecting BACE activity in proteoliposomes: 1. 
anionic glycerophospholipids (whose stimulating effect is potentiated by PE), 2. 
(neutral) glycosphingolipids (cerebrosides), 3. sterols (cholesterol). 
All lipids are capable of affecting multiple properties of the membrane, and 
obviously, properties of individual lipid species are not combined by simple 
additive principles (note for example the effect of PE in combination with PS, 
but not alone, effect of cholesterol, or the effect of cerebrosides). Without 
understanding principles of lateral lipid organization, and without means to 
control vertical lipid organization in artificial systems, we cannot completely 
mimic the conditions in the native environment.  
Nevertheless, using the soluble peptide substrate, we demonstrated that 
classical raft lipids - cerebrosides and particularly, cholesterol - promote 
activity of BACE in proteoliposomes. So far, all results that have been 
discussed had been obtained with the simplistic experimental set-up involving 
cleavage of soluble artificial substrate by reconstituted BACE. Such 
simplification is useful to identify lipids influencing solely BACE as an enzyme, 
but cannot reveal how the β-processing may be affected due to an interaction 
of a lipid with APP or owing to the partitioning of APP and BACE in raft-like 
domains. To recapitulate the mechanisms by which lipids could be involved in 
Cholesterol  
Conclusion I 
Anionic GPL, 
GSL, and 
cholesterol 
stimulate 
BACE 
activity  
From simple 
system to 
reconstitution 
of the real β-
cleavage 
Discussion  63 
Lucie Kalvodova  Lipid requirements for β-secretase activity of BACE 
regulation of the β-cleavage (Figure 22): 1. lipids as directly interacting 
partners for either APP or BACE, 2. lipids shaping the overall bulk properties 
of the membrane and thus indirectly influencing the state (for example 
conformation) of either APP and BACE, 3. lipids determining the domain 
organization of the membrane and hence providing means to bring APP and 
BACE together or to keep them apart, 4 - extending point 3: facilitating 
trafficking of BACE and APP within the cell. 
Adapted from Ehehalt, Keller, Haass, Thiele and
Simons, JCB 160 (2003), 113
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Figure 22 Possible modes of action of lipids on APP and BACE. Panel A - particular lipid 
species or particular lipid composition may support certain conformational state of 
APP/BACE, Panel B - lipid rafts had been suggested to serve as interaction platforms for 
APP and BACE, mediating their coming together and facilitating endocytosis 
The fourth point had been addressed previously in this lab [51], and has been 
the main influence for the formulation of the hypothesis implicating rafts in β-
processing. In this study it has been shown that under the conditions of 
inhibited endocytosis, the β-cleavage is reduced, however cross-linking of APP 
and BACE can overcome this reduction, suggesting that clustering rafts 
containing APP and BACE on the cell surface can mimic their coming 
together somewhere down the endocytic pathway. Even though fairly clear-cut 
results at a first sight, when analyzed further, several ambiguities surface. The 
finding that most of the β-cleavage happens upon endocytosis was in accord 
with several other studies arguing for the requirement of endocytosis for the β-
processing, however studies claiming the opposite emerged as well [14]. There 
are several reasons that can explain the discrepancies, some of them inherent 
to studies on cells in culture in general. (overexpression of the involved 
proteins and lack of means to decide between direct and indirect effects), and 
some specific for the β-processing study; these include the different approaches 
taken to prevent endocytosis, different methodology to detect the cleavage and 
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neglecting the degradation of the β-cleaved products. In addition, even the 
elegant experiments presented in [51] allow for ambiguous interpretation, since 
one cannot exclude that cross-linking APP and BACE in a theoretical 
environment totally devoid of rafts would nevertheless lead to increased 
cleavage especially under the conditions of overexpressed APP. Therefore in 
order to implicate rafts in cleavage, it may be useful to uncouple the β-
processing step from cellular physiology. 
Proteoliposomes of different lipid compositions, either with or without phase-
separated co-existing lo domains, seem to be an ideal tool to answer questions 
addressing the role of lipid rafts in β-processing. While the role of raft lipids 
(and the role of phase-separated lo domains mimicking the raft environment in 
liposomes) cannot be revealed by probing BACE activity with the soluble 
substrate, it is likely to become obvious when BACE activity is probed towards 
its natural substrate, the co-reconstituted full-length APP. 
We have established that BACE cleaves the co-reconstituted APP in total 
brain lipid liposomes at the correct site, proving our reconstituted system to be 
relevant and well suited for testing the hypothesis of raft-mediated β-cleavage 
of the full-length APP. 
To begin with, we have asked a simple question: is there a detectable difference 
in rate of APP cleavage by BACE in total brain lipid liposomes and POPC 
liposomes? 
Conceptually simple experiment, yet technically not trivial to set up. Such 
assay poses several problems. 
First, unlike ˝every other˝, usual enzymatic in vitro assay, in this assay 
substrate and enzyme are not added separately, but they come together 
embedded in liposomes; thus, one cannot independently control the enzyme 
and substrate concentration∗. Multiple samples were therefore prepared, 
content of APP and BACE was evaluated by dot blotting, and comparable 
samples were used for comparative activity assays. 
Second, since the protease and the substrate are present together from the 
moment of starting the reconstitution procedure, cleavage can happen at any 
stage during the procedure or storage. To a large extent, we have overcome the 
problems of premature cleavage by optimizing the reconstitution procedure 
                                                
∗ one possible way to circumvent this problem would be to use 2 different populations of 
proteoliposomes, one population with APP, and the other with BACE, and fuse them; 
however, this will only be possible when efficient methods for liposome fusion are available. 
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(the parameters that are of highest importance are speed, pH, and 
temperature); nevertheless, this unwanted proteolysis could not be totally 
quenched, which leads to uncertainty about timepoint zero conditions in our 
assay, which is a crucial parameter for kinetic analysis. Third and perhaps 
most critical, achieving favorable APP-to-BACE ratio in proteoliposomes is 
essential.  
The rate of an enzyme-catalyzed conversion of a substrate to a product 
depends on the concentration of the substrate, but only until a certain  
threshold concentration is reached. This threshold corresponds to the so-called 
enzyme saturation. Enzyme saturation is reached when essentially all the 
enzyme is present in the form of enzyme-substrate complex. Under these 
conditions, the rate of conversion holds constant until a point when the 
substrate is depleted below the level necessary for enzyme saturation, and the 
apparent activity of the enzyme thus decreases. Hence, it is possible to 
compare specific enzyme activities in different samples by comparing the 
reaction rates only when the enzyme is saturated; in this situation small 
differences in substrate concentrations do not alter the results. When it is not 
possible to ensure enzyme saturation, it is necessary to work with samples with 
comparable enzyme and substrate concentrations. It is however important to 
point out that in contrast to conventional in vitro enzyme assays in solution (3 
dimensions), where small deviations from ideal concentrations lead to small 
effects, in our assays, where the enzyme and substrate are confined to 2D 
space, at concentrations in the ˝nano-scale“ working range (generally the 
proteoliposome samples contain no more than 20 molecules per vesicle), a small 
difference may lead to dramatic consequences. A typical example of such 
behavior is a situation where BACE content corresponds to an average of 1 
BACE molecule per vesicle. Since the BACE distribution throughout the 
vesicle population is not even, but most likely corresponds to the Poisson 
distribution, this means that there will be vesicles totally lacking BACE as well 
as vesicles with relative BACE excess. This will in the end effect lead to kinetic 
parameters that will describe averaged parameters of these different 
subpopulations of vesicles and this may lead to considerable error in evaluating 
BACE activity. In addition, as mentioned above, one has to bear in mind that 
the present study was based on assays with samples harboring minute amounts 
of the proteins, and it has been shown and studied before that some of the laws 
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that are assumed to  be relevant in the ˝conventional˝ enzyme kinetics are not 
obeyed in small-scale, 2D systems♥. 
We have been aware of these limitations and pitfalls, and the assays were done 
with great care to minimize all the maladies. Results that have been obtained 
to date are encouraging, indicating a slower rate of cleavage of APP in POPC 
liposomes as compared to total brain liposomes. However, while the 
experiments proved to be reproducible in that the total brain liposomes were 
superior to POPC  in terms of rate of the β-cleaved-ectodomain production, 
the saturation levels and the shapes of the enzyme progress curves were less 
reproducible. At this stage it would therefore be dangerous to pronounce any 
truly quantitative statements about kinetic parameters in brain lipids and 
POPC. 
Which are the concrete problems and how to solve them? It appears that one 
serious, yet relatively easy to overcome source of error is the insufficient 
characterization of the initial proteoliposome preparation - it seems that the 
current methodology employed for initial protein quantification was inadequate 
(dot blotting) and that using a more sensitive method (like MSD) would 
improve the quality of the cleavage assays enormously, and render them more 
quantitative. Also characterizing the inter-vesicular distribution of APP and 
BACE (for example by EM) in a quantitative manner may be required as a 
routine step in the assay. 
Nevertheless, the fact that there is a detectable difference between the two, in 
a way extreme, lipid compositions (single component versus multiple 
component) is a highly important finding.  
Thanks to the current rapid progress in characterization of ternary lipid 
mixtures of PC, SM, and cholesterol [90], it seems to be possible to 
experimentally address the issue of impact of the size of the domains on the 
kinetics of β-cleavage. It is likely that if rafts/domains mediate the reaction, 
then the size of the domains, as well as the total amount of each phase, will be 
important parameters influencing the kinetics, as the kinetics of the reaction 
itself cannot be uncoupled from the kinetics and rate of encounters between 
APP and BACE, and these in turn depend on frequency of partitioning in and 
                                                
♥ The foundation of enzyme kinetcs, the Michaelis-Menten formalism for enzyme reactions, is 
based on mass-action laws. Mass-action laws are mean-field approximations because they 
evaluate local reaction rates on the basis of average values of the reactant density over a 
large spatial domain. They rely on strict assumptions concerning, for instance, the 
characteristics of the reaction medium, which must be dilute, perfectly-mixed, three-
dimensional, and homogenous. Many of the required assumptions fail in the case of biological 
reactions and reactions in 2D [92]. 
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out of such domains and on the residency time within. Figure 23 presents a 
possible scheme of controlling the size of the domains in liposomes.  
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Figure 23 Size of the domains depends on lipid composition of the liposomes. The figure was 
conceived based on the data extracted from [90]. The lipid compositions are given as molar 
ratios of the 3 components. Domain size as well as total amount of the phases is likely to 
have profound effect on kinetics of any raft/lo-domain mediated enzymatic reaction. 
Another important area to explore is the issue of cross-linking and the effects it 
may bring about. The present system - phase separating proteoliposomes 
comprising a ˝raftophilic˝ enzyme (BACE) and its substrate (APP), which, on 
its own, does not seem to display any significant raft-partitioning ability, 
appears to be a powerful tool for studying phenomena affecting partitioning of 
the incorporated proteins. 
Considering the growing number of studies contributing to deciphering the 
complicated picture of how proteins and lipids diffuse and interact in biological 
membranes [69, 91, 92], it is clear that this issue has become one of the 
mainstreams of cell biology research, and thus we can hope that this increased 
interest will accelerate our uncovering of how lipids of the cell membranes may 
be involved in contributing to the development of Alzheimer‘s disease, and how 
can we make use of this knowledge in medical research. 
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